{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 562, "items": [{"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T03:32:08Z", "timestamp": 1574134328465}, "reference-count": 77, "publisher": "Elsevier BV", "issue": "3", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2002, 9, 1]], "date-time": "2002-09-01T00:00:00Z", "timestamp": 1030838400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Urology"], "published-print": {"date-parts": [[2002, 9]]}, "DOI": "10.1016/s0090-4295(02)01593-5", "type": "journal-article", "created": {"date-parts": [[2002, 10, 11]], "date-time": "2002-10-11T01:05:50Z", "timestamp": 1034298350000}, "page": "132-138", "source": "Crossref", "is-referenced-by-count": 157, "title": ["Androgen receptor as a target in androgen-independent prostate cancer"], "prefix": "10.1016", "volume": "60", "author": [{"given": "Steven P", "family": "Balk", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Urology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0090429502015935?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0090429502015935?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 9]], "date-time": "2019-04-09T18:25:04Z", "timestamp": 1554834304000}, "score": 66.78399, "issued": {"date-parts": [[2002, 9]]}, "references-count": 77, "journal-issue": {"published-print": {"date-parts": [[2002, 9]]}, "issue": "3"}, "alternative-id": ["S0090429502015935"], "URL": "http://dx.doi.org/10.1016/s0090-4295(02)01593-5", "ISSN": ["0090-4295"], "issn-type": [{"value": "0090-4295", "type": "print"}]}, {"institution": {"name": "US Dept of the Army", "place": ["-", "-"], "department": ["Funding", "Performing"], "acronym": ["USAMRMC", "-"]}, "indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T22:44:14Z", "timestamp": 1574808254849}, "publisher-location": "Fort Belvoir, VA", "reference-count": 0, "publisher": "Defense Technical Information Center", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2011, 6, 1]]}, "DOI": "10.21236/ada547188", "type": "report", "created": {"date-parts": [[2017, 7, 10]], "date-time": "2017-07-10T22:43:54Z", "timestamp": 1499726634000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Androgen Metabolism in Progression to Androgen-Independent Prostate Cancer"], "prefix": "10.21236", "author": [{"given": "Steven", "family": "Balk", "sequence": "first", "affiliation": []}], "member": "9879", "original-title": [""], "deposited": {"date-parts": [[2017, 7, 10]], "date-time": "2017-07-10T22:43:55Z", "timestamp": 1499726635000}, "score": 62.16718, "subtitle": [""], "issued": {"date-parts": [[2011, 6, 1]]}, "references-count": 0, "URL": "http://dx.doi.org/10.21236/ada547188"}, {"institution": {"name": "US Dept of the Army", "place": ["-", "-"], "department": ["Funding", "Performing"], "acronym": ["USAMRMC", "-"]}, "indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T00:57:22Z", "timestamp": 1574816242214}, "publisher-location": "Fort Belvoir, VA", "reference-count": 0, "publisher": "Defense Technical Information Center", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2008, 6, 1]]}, "DOI": "10.21236/ada502868", "type": "report", "created": {"date-parts": [[2017, 7, 28]], "date-time": "2017-07-28T11:42:34Z", "timestamp": 1501242154000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Androgen Metabolism in Progression to Androgen-Independent Prostate Cancer"], "prefix": "10.21236", "author": [{"given": "Steven P.", "family": "Balk", "sequence": "first", "affiliation": []}], "member": "9879", "original-title": [""], "deposited": {"date-parts": [[2017, 7, 28]], "date-time": "2017-07-28T11:42:34Z", "timestamp": 1501242154000}, "score": 60.835293, "subtitle": [""], "issued": {"date-parts": [[2008, 6, 1]]}, "references-count": 0, "URL": "http://dx.doi.org/10.21236/ada502868"}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T15:58:07Z", "timestamp": 1575475087382}, "reference-count": 47, "publisher": "Medknow", "issue": "4", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Asian J Androl"], "published-print": {"date-parts": [[2014]]}, "DOI": "10.4103/1008-682x.126396", "type": "journal-article", "created": {"date-parts": [[2014, 5, 14]], "date-time": "2014-05-14T11:05:27Z", "timestamp": 1400065527000}, "page": "561", "source": "Crossref", "is-referenced-by-count": 5, "title": ["Androgen receptor functions in prostate cancer development and progression"], "prefix": "10.4103", "volume": "16", "author": [{"given": "StevenP", "family": "Balk", "sequence": "first", "affiliation": []}], "member": "2581", "container-title": ["Asian Journal of Andrology"], "language": "en", "deposited": {"date-parts": [[2017, 6, 22]], "date-time": "2017-06-22T13:11:05Z", "timestamp": 1498137065000}, "score": 48.35731, "issued": {"date-parts": [[2014]]}, "references-count": 47, "journal-issue": {"published-print": {"date-parts": [[2014]]}, "issue": "4"}, "alternative-id": ["126396"], "URL": "http://dx.doi.org/10.4103/1008-682x.126396", "ISSN": ["1008-682X"], "issn-type": [{"value": "1008-682X", "type": "print"}], "subject": ["Urology", "General Medicine"]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T17:30:29Z", "timestamp": 1575221429077}, "reference-count": 0, "publisher": "American Association for Cancer Research (AACR)", "issue": "4 Supplement", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cancer Research"], "published-print": {"date-parts": [[2012, 2, 6]]}, "DOI": "10.1158/1538-7445.prca2012-c3", "type": "journal-article", "created": {"date-parts": [[2013, 5, 9]], "date-time": "2013-05-09T18:50:37Z", "timestamp": 1368125437000}, "page": "C3-C3", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Abstract C3: Receptor tyrosine kinase(s) modulate androgen receptor signaling in castrate-resistant prostate cancer"], "prefix": "10.1158", "volume": "72", "author": [{"given": "A.", "family": "Sharma", "sequence": "first", "affiliation": []}, {"given": "S. P.", "family": "Balk", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2013, 5, 9]]}, "container-title": ["Cancer Research"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1538-7445.PRCA2012-C3", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T12:24:17Z", "timestamp": 1482495857000}, "score": 45.68509, "issued": {"date-parts": [[2012, 2, 6]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2013, 5, 9]]}, "published-print": {"date-parts": [[2012, 2, 6]]}, "issue": "4 Supplement"}, "URL": "http://dx.doi.org/10.1158/1538-7445.prca2012-c3", "ISSN": ["0008-5472", "1538-7445"], "issn-type": [{"value": "0008-5472", "type": "print"}, {"value": "1538-7445", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T00:34:53Z", "timestamp": 1574296493443}, "publisher-location": "New York, NY", "reference-count": 72, "publisher": "Springer US", "isbn-type": [{"value": "9780387691770", "type": "print"}, {"value": "9780387691794", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2009]]}, "DOI": "10.1007/978-0-387-69179-4_5", "type": "book-chapter", "created": {"date-parts": [[2009, 4, 18]], "date-time": "2009-04-18T16:59:37Z", "timestamp": 1240073977000}, "page": "123-139", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Increased Expression of Genes Converting Adrenal Androgens to Testosterone in Castration-Recurrent Prostate Cancer"], "prefix": "10.1007", "author": [{"given": "Steven P.", "family": "Balk", "sequence": "first", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2009, 3, 27]]}, "reference": [{"key": "5_CR1_5", "doi-asserted-by": "publisher", "first-page": "37", "DOI": "10.1016/0960-0760(95)00039-3", "volume": "53", "author": "S. Andersson", "year": "1995", "unstructured": "Andersson, S., Geissler, W.M., Patel, S., and Wu, L.(1995). The molecular biology of androgenic 17 beta-hydroxysteroid dehydrogenases. J. Steroid Biochem. Mol. Biol.53, 37\u201339.", "journal-title": "J. Steroid Biochem. Mol. Biol."}, {"key": "5_CR2_5", "doi-asserted-by": "publisher", "first-page": "3100", "DOI": "10.1073/pnas.0510842103", "volume": "103", "author": "S.H. Baek", "year": "2006", "unstructured": "Baek, S.H., Ohgi, K.A., Nelson, C.A., Welsbie, D., Chen, C., Sawyers, C.L., Rose, D.W., and Rosenfeld, M.G.(2006). Ligand-specific allosteric regulation of coactivator functions of androgen receptor in prostate cancer cells. Proc. Natl. Acad. Sci. U. S. A103, 3100\u20133105.", "journal-title": "Proc. Natl. Acad. Sci. U. S. A"}, {"key": "5_CR3_5", "doi-asserted-by": "publisher", "first-page": "5806", "DOI": "10.1210/en.2006-0627", "volume": "147", "author": "D.R. Bauman", "year": "2006a", "unstructured": "Bauman, D.R., Steckelbroeck, S., Peehl, D.M., and Penning, T.M.(2006a). Transcript profiling of the androgen signal in normal prostate, benign prostatic hyperplasia, and prostate cancer. Endocrinology147, 5806\u20135816.", "journal-title": "Endocrinology"}, {"key": "5_CR4_5", "doi-asserted-by": "publisher", "first-page": "444", "DOI": "10.1210/me.2005-0287", "volume": "20", "author": "D.R. Bauman", "year": "2006b", "unstructured": "Bauman, D.R., Steckelbroeck, S., Williams, M.V., Peehl, D.M., and Penning, T.M.(2006b). Identification of the major oxidative 3alpha-hydroxysteroid dehydrogenase in human prostate that converts 5alpha-androstane-3alpha,17beta-diol to 5alpha-dihydrotestosterone: a potential therapeutic target for androgen-dependent disease. Mol. Endocrinol.20, 444\u2013458.", "journal-title": "Mol. Endocrinol."}, {"key": "5_CR5_5", "doi-asserted-by": "publisher", "first-page": "473", "DOI": "10.1016/j.tem.2003.10.005", "volume": "14", "author": "A. Belanger", "year": "2003", "unstructured": "Belanger, A., Pelletier, G., Labrie, F., Barbier, O., and Chouinard, S.(2003). Inactivation of androgens by UDP-glucuronosyltransferase enzymes in humans. Trends Endocrinol. Metab.14, 473\u2013479.", "journal-title": "Trends Endocrinol. Metab."}, {"key": "5_CR6_5", "doi-asserted-by": "publisher", "first-page": "695", "DOI": "10.1016/0022-4731(89)90514-1", "volume": "32", "author": "B. Belanger", "year": "1989", "unstructured": "Belanger, B., Belanger, A., Labrie, F., Dupont, A., Cusan, L., and Monfette, G.(1989). Comparison of residual C-19 steroids in plasma and prostatic tissue of human, rat and guinea pig after castration: unique importance of extratesticular androgens in men. J. Steroid Biochem.32, 695\u2013698.", "journal-title": "J. Steroid Biochem."}, {"key": "5_CR7_5", "doi-asserted-by": "publisher", "first-page": "2210", "DOI": "10.1210/jc.82.7.2210", "volume": "82", "author": "C. Bjelfman", "year": "1997", "unstructured": "Bjelfman, C., Soderstrom, T.G., Brekkan, E., Norlen, B.J., Egevad, L., Unge, T., Andersson, S., and Rane, A.(1997). Differential gene expression of steroid 5 alpha-reductase 2 in core needle biopsies from malignant and benign prostatic tissue. J. Clin. Endocrinol. Metab82, 2210\u20132214.", "journal-title": "J. Clin. Endocrinol. Metab"}, {"key": "5_CR8_5", "doi-asserted-by": "publisher", "first-page": "261", "DOI": "10.1002/(SICI)1097-0045(199610)29:4<261::AID-PROS7>3.0.CO;2-E", "volume": "29", "author": "H. Bonkhoff", "year": "1996", "unstructured": "Bonkhoff, H., Stein, U., Aumuller, G., and Remberger, K.(1996). Differential expression of 5 alpha-reductase isoenzymes in the human prostate and prostatic carcinomas. Prostate29, 261\u2013267.", "journal-title": "Prostate"}, {"key": "5_CR9_5", "doi-asserted-by": "publisher", "first-page": "33", "DOI": "10.1038/nm972", "volume": "10", "author": "C.D. Chen", "year": "2004", "unstructured": "Chen, C.D., Welsbie, D.S., Tran, C., Baek, S.H., Chen, R., Vessella, R., Rosenfeld, M.G., and Sawyers, C.L.(2004). Molecular determinants of resistance to antiandrogen therapy. Nat. Med.10, 33\u201339.", "journal-title": "Nat. Med."}, {"key": "5_CR10_5", "doi-asserted-by": "publisher", "first-page": "1492", "DOI": "10.1210/me.16.7.1492", "volume": "16", "author": "S. Cheng", "year": "2002", "unstructured": "Cheng, S., Brzostek, S., Lee, S.R., Hollenberg, A.N., and Balk, S.P.(2002). Inhibition of the dihydrotestosterone-activated androgen receptor by nuclear receptor corepressor. Mol. Endocrinol.16, 1492\u20131501.", "journal-title": "Mol. Endocrinol."}, {"key": "5_CR11_5", "doi-asserted-by": "publisher", "first-page": "717", "DOI": "10.1081/ERC-200044014", "volume": "30", "author": "S. Chouinard", "year": "2004", "unstructured": "Chouinard, S., Pelletier, G., Belanger, A., and Barbier, O.(2004). Cellular specific expression of the androgen-conjugating enzymes UGT2B15 and UGT2B17 in the human prostate epithelium. Endocr. Res.30, 717\u2013725.", "journal-title": "Endocr. Res."}, {"key": "5_CR12_5", "doi-asserted-by": "publisher", "first-page": "5431", "DOI": "10.1210/en.2006-0229", "volume": "147", "author": "S. Chouinard", "year": "2006", "unstructured": "Chouinard, S., Pelletier, G., Belanger, A., and Barbier, O.(2006). Isoform-specific regulation of uridine diphosphate-glucuronosyltransferase 2B enzymes in the human prostate: differential consequences for androgen and bioactive lipid inactivation. Endocrinology147, 5431\u20135442.", "journal-title": "Endocrinology"}, {"key": "5_CR13_5", "first-page": "505", "volume": "63", "author": "J.C. Desmond", "year": "2003", "unstructured": "Desmond, J.C., Mountford, J.C., Drayson, M.T., Walker, E.A., Hewison, M., Ride, J.P., Luong, Q.T., Hayden, R.E., Vanin, E.F., and Bunce, C.M.(2003). The aldo-keto reductase AKR1C3 is a novel suppressor of cell differentiation that provides a plausible target for the non-cyclooxygenase-dependent antineoplastic actions of nonsteroidal anti-inflammatory drugs. Cancer Res.63, 505\u2013512.", "journal-title": "Cancer Res."}, {"key": "5_CR14_5", "doi-asserted-by": "publisher", "first-page": "568", "DOI": "10.1210/en.140.2.568", "volume": "140", "author": "I. Dufort", "year": "1999", "unstructured": "Dufort, I., Rheault, P., Huang, X.F., Soucy, P., and Luu-The, V.(1999). Characteristics of a highly labile human type 5 17beta-hydroxysteroid dehydrogenase. Endocrinology140, 568\u2013574.", "journal-title": "Endocrinology"}, {"key": "5_CR15_5", "doi-asserted-by": "publisher", "first-page": "1481", "DOI": "10.1210/en.140.3.1481", "volume": "140", "author": "M. El Alfy", "year": "1999", "unstructured": "El Alfy, M., Luu-The, V., Huang, X.F., Berger, L., Labrie, F., and Pelletier, G.(1999). Localization of type 5 17beta-hydroxysteroid dehydrogenase, 3beta-hydroxysteroid dehydrogenase, and androgen receptor in the human prostate by in situ hybridization and immunocytochemistry. Endocrinology140, 1481\u20131491.", "journal-title": "Endocrinology"}, {"key": "5_CR16_5", "doi-asserted-by": "publisher", "first-page": "37", "DOI": "10.1002/(SICI)1097-0215(19960328)66:1<37::AID-IJC7>3.0.CO;2-#", "volume": "66", "author": "J.P. Elo", "year": "1996", "unstructured": "Elo, J.P., Akinola, L.A., Poutanen, M., Vihko, P., Kyllonen, A.P., Lukkarinen, O., and Vihko, R.(1996). Characterization of 17beta-hydroxysteroid dehydrogenase isoenzyme expression in benign and malignant human prostate. Int. J. Cancer66, 37\u201341.", "journal-title": "Int. J. Cancer"}, {"key": "5_CR17_5", "doi-asserted-by": "publisher", "first-page": "2212", "DOI": "10.1158/0008-5472.CAN-2148-2", "volume": "64", "author": "S.L. Ettinger", "year": "2004", "unstructured": "Ettinger, S.L., Sobel, R., Whitmore, T.G., Akbari, M., Bradley, D.R., Gleave, M.E., and Nelson, C.C.(2004). Dysregulation of sterol response element-binding proteins and downstream effectors in prostate cancer during progression to androgen independence. Cancer Res.64, 2212\u20132221.", "journal-title": "Cancer Res."}, {"key": "5_CR18_5", "doi-asserted-by": "publisher", "first-page": "448", "DOI": "10.1016/S0022-5347(01)67071-X", "volume": "154", "author": "J.E. Fowler Jr", "year": "1995", "unstructured": "Fowler, J.E., Jr., Pandey, P., Seaver, L.E., and Feliz, T.P.(1995). Prostate specific antigen after gonadal androgen withdrawal and deferred flutamide treatment. J. Urol.154, 448\u2013453.", "journal-title": "J. Urol."}, {"key": "5_CR19_5", "doi-asserted-by": "publisher", "first-page": "174", "DOI": "10.1002/ijc.20704", "volume": "114", "author": "G. Fromont", "year": "2005", "unstructured": "Fromont, G., Chene, L., Vidaud, M., Vallancien, G., Mangin, P., Fournier, G., Validire, P., Latil, A., and Cussenot, O.(2005). Differential expression of 37 selected genes in hormone-refractory prostate cancer using quantitative taqman real-time RT-PCR. Int. J. Cancer114, 174\u2013181.", "journal-title": "Int. J. Cancer"}, {"key": "5_CR20_5", "doi-asserted-by": "publisher", "first-page": "169", "DOI": "10.1677/erc.1.01048", "volume": "13", "author": "K.M. Fung", "year": "2006", "unstructured": "Fung, K.M., Samara, E.N., Wong, C., Metwalli, A., Krlin, R., Bane, B., Liu, C.Z., Yang, J.T., Pitha, J.V., Culkin, D.J., Kropp, B.P., Penning, T.M., and Lin, H.K.(2006). Increased expression of type 2 3alpha-hydroxysteroid dehydrogenase/type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3) and its relationship with androgen receptor in prostate carcinoma. Endocr. Relat. Cancer13, 169\u2013180.", "journal-title": "Endocr. Relat. Cancer"}, {"key": "5_CR21_5", "first-page": "28", "volume": "12", "author": "J. Geller", "year": "1985", "unstructured": "Geller, J.(1985). Rationale for blockade of adrenal as well as testicular androgens in the treatment of advanced prostate cancer. Semin. Oncol.12, 28\u201335.", "journal-title": "Semin. Oncol."}, {"key": "5_CR22_5", "doi-asserted-by": "publisher", "first-page": "151", "DOI": "10.1007/BF00254427", "volume": "15", "author": "J. Geller", "year": "1987", "unstructured": "Geller, J. and Albert, J.(1987). Effects of castration compared with total androgen blockade on tissue dihydrotestosterone (DHT) concentration in benign prostatic hyperplasia (BPH). Urol. Res.15, 151\u2013153.", "journal-title": "Urol. Res."}, {"key": "5_CR23_5", "doi-asserted-by": "crossref", "first-page": "693", "DOI": "10.1016/S0022-5347(17)49829-6", "volume": "132", "author": "J. Geller", "year": "1984", "unstructured": "Geller, J., Albert, J.D., Nachtsheim, D.A., and Loza, D.(1984). Comparison of prostatic cancer tissue dihydrotestosterone levels at the time of relapse following orchiectomy or estrogen therapy. J. Urol.132, 693\u2013696.", "journal-title": "J. Urol."}, {"key": "5_CR24_5", "doi-asserted-by": "publisher", "first-page": "4573", "DOI": "10.1210/en.140.10.4573", "volume": "140", "author": "S. Gingras", "year": "1999", "unstructured": "Gingras, S. and Simard, J.(1999). Induction of 3beta-hydroxysteroid dehydrogenase/isomerase type 1 expression by interleukin-4 in human normal prostate epithelial cells, immortalized keratinocytes, colon, and cervix cancer cell lines. Endocrinology140, 4573\u20134584.", "journal-title": "Endocrinology"}, {"key": "5_CR25_5", "doi-asserted-by": "publisher", "first-page": "2872", "DOI": "10.1210/en.137.7.2872", "volume": "137", "author": "C. Guillemette", "year": "1996", "unstructured": "Guillemette, C., Hum, D.W., and Belanger, A.(1996). Regulation of steroid glucuronosyltransferase activities and transcripts by androgen in the human prostatic cancer LNCaP cell line. Endocrinology137, 2872\u20132879.", "journal-title": "Endocrinology"}, {"key": "5_CR26_5", "doi-asserted-by": "publisher", "first-page": "705", "DOI": "10.1210/jc.2002-020236", "volume": "88", "author": "P. Harkonen", "year": "2003", "unstructured": "Harkonen, P., Torn, S., Kurkela, R., Porvari, K., Pulkka, A., Lindfors, A., Isomaa, V., and Vihko, P.(2003). Sex hormone metabolism in prostate cancer cells during transition to an androgen-independent state. J. Clin. Endocrinol. Metab.88, 705\u2013712.", "journal-title": "J. Clin. Endocrinol. Metab."}, {"key": "5_CR27_5", "doi-asserted-by": "publisher", "first-page": "3843", "DOI": "10.1210/en.2006-0358", "volume": "147", "author": "W.R. Harrington", "year": "2006", "unstructured": "Harrington, W.R., Sengupta, S., and Katzenellenbogen, B.S.(2006). Estrogen regulation of the glucuronidation enzyme UGT2B15 in estrogen receptor-positive breast cancer cells. Endocrinology147, 3843\u20133850.", "journal-title": "Endocrinology"}, {"key": "5_CR28_5", "doi-asserted-by": "publisher", "first-page": "1817", "DOI": "10.1210/me.15.10.1817", "volume": "15", "author": "H. Heemers", "year": "2001", "unstructured": "Heemers, H., Maes, B., Foufelle, F., Heyns, W., Verhoeven, G., and Swinnen, J.V.(2001). Androgens stimulate lipogenic gene expression in prostate cancer cells by activation of the sterol regulatory element-binding protein cleavage activating protein/sterol regulatory element-binding protein pathway. Mol. Endocrinol.15, 1817\u20131828.", "journal-title": "Mol. Endocrinol."}, {"key": "5_CR29_5", "doi-asserted-by": "publisher", "first-page": "8388", "DOI": "10.1158/0008-5472.CAN-07-0617", "volume": "67", "author": "M.C. Hodgson", "year": "2007", "unstructured": "Hodgson, M.C., Astapova, I., Hollenberg, A.N., and Balk, S.P.(2007). Activity of androgen receptor antagonist bicalutamide in prostate cancer cells is independent of NCoR and SMRT corepressors. Cancer Res.67, 8388\u20138395.", "journal-title": "Cancer Res."}, {"key": "5_CR30_5", "doi-asserted-by": "publisher", "first-page": "217", "DOI": "10.1016/S0002-9440(10)63112-4", "volume": "164", "author": "J. Holzbeierlein", "year": "2004", "unstructured": "Holzbeierlein, J., Lal, P., LaTulippe, E., Smith, A., Satagopan, J., Zhang, L., Ryan, C., Smith, S., Scher, H., Scardino, P., Reuter, V., and Gerald, W.L.(2004). Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance. Am. J. Pathol.164, 217\u2013227.", "journal-title": "Am. J. Pathol."}, {"key": "5_CR31_5", "doi-asserted-by": "publisher", "first-page": "189", "DOI": "10.1016/S0960-0760(99)00030-8", "volume": "68", "author": "C. Iehle", "year": "1999", "unstructured": "Iehle, C., Radvanyi, F., Gil Diez de, M., Ouafik, L.H., Gerard, H., Chopin, D., Raynaud, J.P., and Martin, P.M.(1999). Differences in steroid 5alpha-reductase iso-enzymes expression between normal and pathological human prostate tissue. J. Steroid Biochem. Mol. Biol.68, 189\u2013195.", "journal-title": "J. Steroid Biochem. Mol. Biol."}, {"key": "5_CR32_5", "doi-asserted-by": "publisher", "first-page": "1361", "DOI": "10.1158/0008-5472.CAN-06-1593", "volume": "67", "author": "Q. Ji", "year": "2007", "unstructured": "Ji, Q., Chang, L., Stanczyk, F.Z., Ookhtens, M., Sherrod, A., and Stolz, A.(2007). Impaired dihydrotestosterone catabolism in human prostate cancer: critical role of AKR1C2 as a pre-receptor regulator of androgen receptor signaling. Cancer Res.67, 1361\u20131369.", "journal-title": "Cancer Res."}, {"key": "5_CR33_5", "doi-asserted-by": "publisher", "first-page": "275", "DOI": "10.1002/pros.10192", "volume": "54", "author": "Q. Ji", "year": "2003", "unstructured": "Ji, Q., Chang, L., VanDenBerg, D., Stanczyk, F.Z., and Stolz, A.(2003). Selective reduction of AKR1C2 in prostate cancer and its role in DHT metabolism. Prostate54, 275\u2013289.", "journal-title": "Prostate"}, {"key": "5_CR34_5", "doi-asserted-by": "publisher", "first-page": "149", "DOI": "10.1016/S0022-5347(01)64039-4", "volume": "159", "author": "R. Joyce", "year": "1998", "unstructured": "Joyce, R., Fenton, M.A., Rode, P., Constantine, M., Gaynes, L., Kolvenbag, G., DeWolf, W., Balk, S., Taplin, M.E., and Bubley, G.J.(1998). High dose bicalutamide for androgen independent prostate cancer: effect of prior hormonal therapy. J. Urol.159, 149\u2013153.", "journal-title": "J. Urol."}, {"key": "5_CR35_5", "doi-asserted-by": "publisher", "first-page": "2188", "DOI": "10.1021/bi036046x", "volume": "43", "author": "J. Komoto", "year": "2004", "unstructured": "Komoto, J., Yamada, T., Watanabe, K., and Takusagawa, F.(2004). Crystal structure of human prostaglandin F synthase (AKR1C3). Biochemistry43, 2188\u20132198.", "journal-title": "Biochemistry"}, {"key": "5_CR36_5", "doi-asserted-by": "publisher", "first-page": "615", "DOI": "10.1016/0022-4731(79)90090-6", "volume": "11", "author": "M. Krieg", "year": "1979", "unstructured": "Krieg, M., Bartsch, W., Janssen, W., and Voigt, K.D.(1979). A comparative study of binding, metabolism and endogenous levels of androgens in normal, hyperplastic and carcinomatous human prostate. J. Steroid Biochem.11, 615\u2013624.", "journal-title": "J. Steroid Biochem."}, {"key": "5_CR37_5", "doi-asserted-by": "publisher", "first-page": "421", "DOI": "10.1016/S1043-2760(00)00342-8", "volume": "11", "author": "F. Labrie", "year": "2000", "unstructured": "Labrie, F., Luu-The, V., Lin, S.X., Simard, J., and Labrie, C.(2000). Role of 17 beta-hydroxysteroid dehydrogenases in sex steroid formation in peripheral intracrine tissues. Trends Endocrinol. Metab.11, 421\u2013427.", "journal-title": "Trends Endocrinol. Metab."}, {"key": "5_CR38_5", "doi-asserted-by": "publisher", "first-page": "1971", "DOI": "10.1210/me.11.13.1971", "volume": "11", "author": "H.K. Lin", "year": "1997", "unstructured": "Lin, H.K., Jez, J.M., Schlegel, B.P., Peehl, D.M., Pachter, J.A., and Penning, T.M.(1997). Expression and characterization of recombinant type 2 3 alpha-hydroxysteroid dehydrogenase (HSD) from human prostate: demonstration of bifunctional 3 alpha/17 beta-HSD activity and cellular distribution. Mol. Endocrinol.11, 1971\u20131984.", "journal-title": "Mol. Endocrinol."}, {"key": "5_CR39_5", "doi-asserted-by": "publisher", "first-page": "795", "DOI": "10.1016/j.steroids.2004.09.014", "volume": "69", "author": "H.K. Lin", "year": "2004", "unstructured": "Lin, H.K., Steckelbroeck, S., Fung, K.M., Jones, A.N., and Penning, T.M.(2004). Characterization of a monoclonal antibody for human aldo-keto reductase AKR1C3 (type 2 3alpha-hydroxysteroid dehydrogenase/type 5 17beta-hydroxysteroid dehydrogenase); immunohistochemical detection in breast and prostate. Steroids69, 795\u2013801.", "journal-title": "Steroids"}, {"key": "5_CR40_5", "doi-asserted-by": "publisher", "first-page": "134", "DOI": "10.1002/pros.10284", "volume": "57", "author": "J. Luo", "year": "2003", "unstructured": "Luo, J., Dunn, T.A., Ewing, C.M., Walsh, P.C., and Isaacs, W.B.(2003). Decreased gene expression of steroid 5 alpha-reductase 2 in human prostate cancer: implications for finasteride therapy of prostate carcinoma. Prostate57, 134\u2013139.", "journal-title": "Prostate"}, {"key": "5_CR41_5", "doi-asserted-by": "crossref", "first-page": "936", "DOI": "10.1016/S0022-5347(17)60911-X", "volume": "108", "author": "E.M. Mahoney", "year": "1972", "unstructured": "Mahoney, E.M. and Harrison, J.H.(1972). Bilateral adrenalectomy for palliative treatment of prostatic cancer. J. Urol.108, 936\u2013938.", "journal-title": "J. Urol."}, {"key": "5_CR42_5", "doi-asserted-by": "publisher", "first-page": "26321", "DOI": "10.1074/jbc.M203310200", "volume": "277", "author": "D. Masiello", "year": "2002", "unstructured": "Masiello, D., Cheng, S., Bubley, G.J., Lu, M.L., and Balk, S.P.(2002). Bicalutamide functions as an androgen receptor antagonist by assembly of a transcriptionally inactive receptor. J. Biol. Chem.277, 26321\u201326326.", "journal-title": "J. Biol. Chem."}, {"key": "5_CR43_5", "doi-asserted-by": "crossref", "first-page": "940", "DOI": "10.1093/oxfordjournals.jbchem.a022211", "volume": "124", "author": "K. Matsuura", "year": "1998", "unstructured": "Matsuura, K., Shiraishi, H., Hara, A., Sato, K., Deyashiki, Y., Ninomiya, M., and Sakai, S.(1998). Identification of a principal mRNA species for human 3alpha-hydroxysteroid dehydrogenase isoform (AKR1C3) that exhibits high prostaglandin D2 11-ketoreductase activity. J. Biochem.124, 940\u2013946.", "journal-title": "J. Biochem."}, {"key": "5_CR44_5", "doi-asserted-by": "publisher", "first-page": "11083", "DOI": "10.1073/pnas.95.19.11083", "volume": "95", "author": "H. Miyamoto", "year": "1998", "unstructured": "Miyamoto, H., Yeh, S., Lardy, H., Messing, E., and Chang, C.(1998). Delta5-androstenediol is a natural hormone with androgenic activity in human prostate cancer cells. Proc. Natl. Acad. Sci. U. S. A95, 11083\u201311088.", "journal-title": "Proc. Natl. Acad. Sci. U. S. A"}, {"key": "5_CR45_5", "doi-asserted-by": "publisher", "first-page": "765", "DOI": "10.1158/0008-5472.CAN-03-0130", "volume": "64", "author": "A. Mizokami", "year": "2004", "unstructured": "Mizokami, A., Koh, E., Fujita, H., Maeda, Y., Egawa, M., Koshida, K., Honma, S., Keller, E.T., and Namiki, M.(2004). The adrenal androgen androstenediol is present in prostate cancer tissue after androgen deprivation therapy and activates mutated androgen receptor. Cancer Res.64, 765\u2013771.", "journal-title": "Cancer Res."}, {"key": "5_CR46_5", "doi-asserted-by": "publisher", "first-page": "440", "DOI": "10.1158/1078-0432.CCR-1146-03", "volume": "10", "author": "J.L. Mohler", "year": "2004", "unstructured": "Mohler, J.L., Gregory, C.W., Ford, O.H., III, Kim, D., Weaver, C.M., Petrusz, P., Wilson, E.M., and French, F.S.(2004). The androgen axis in recurrent prostate cancer. Clin. Cancer Res.10, 440\u2013448.", "journal-title": "Clin. Cancer Res."}, {"key": "5_CR47_5", "doi-asserted-by": "publisher", "first-page": "7121", "DOI": "10.1158/1078-0432.CCR-04-0913", "volume": "10", "author": "T. Nishiyama", "year": "2004", "unstructured": "Nishiyama, T., Hashimoto, Y., and Takahashi, K.(2004). The influence of androgen deprivation therapy on dihydrotestosterone levels in the prostatic tissue of patients with prostate cancer. Clin. Cancer Res.10, 7121\u20137126.", "journal-title": "Clin. Cancer Res."}, {"key": "5_CR48_5", "doi-asserted-by": "publisher", "first-page": "3850", "DOI": "10.1210/jc.2006-0968", "volume": "91", "author": "S.T. Page", "year": "2006", "unstructured": "Page, S.T., Lin, D.W., Mostaghel, E.A., Hess, D.L., True, L.D., Amory, J.K., Nelson, P.S., Matsumoto, A.M., and Bremner, W.J.(2006). Persistent intraprostatic androgen concentrations after medical castration in healthy men. J. Clin. Endocrinol. Metab91, 3850\u20133856.", "journal-title": "J. Clin. Endocrinol. Metab"}, {"key": "5_CR49_5", "doi-asserted-by": "publisher", "first-page": "731", "DOI": "10.1177/002215549904700602", "volume": "47", "author": "G. Pelletier", "year": "1999", "unstructured": "Pelletier, G., Luu-The, V., Tetu, B., and Labrie, F.(1999). Immunocytochemical localization of type 5 17beta-hydroxysteroid dehydrogenase in human reproductive tissues. J. Histochem. Cytochem.47, 731\u2013738.", "journal-title": "J. Histochem. Cytochem."}, {"key": "5_CR50_5", "doi-asserted-by": "publisher", "first-page": "77", "DOI": "10.1016/j.mce.2006.12.007", "volume": "265\u2013266", "author": "T.M. Penning", "year": "2007", "unstructured": "Penning, T.M., Bauman, D.R., Jin, Y., and Rizner, T.L.(2007). Identification of the molecular switch that regulates access of 5alpha-DHT to the androgen receptor. Mol. Cell Endocrinol. 265\u2013266, 77\u201382.", "journal-title": "Mol. Cell Endocrinol"}, {"key": "5_CR51_5", "doi-asserted-by": "publisher", "first-page": "67", "DOI": "10.1042/0264-6021:3510067", "volume": "351", "author": "T.M. Penning", "year": "2000", "unstructured": "Penning, T.M., Burczynski, M.E., Jez, J.M., Hung, C.F., Lin, H.K., Ma, H., Moore, M., Palackal, N., and Ratnam, K.(2000). Human 3alpha-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones. Biochem. J.351, 67\u201377.", "journal-title": "Biochem. J."}, {"key": "5_CR52_5", "doi-asserted-by": "publisher", "first-page": "182", "DOI": "10.1016/j.mce.2005.12.009", "volume": "248", "author": "T.M. Penning", "year": "2006", "unstructured": "Penning, T.M., Steckelbroeck, S., Bauman, D.R., Miller, M.W., Jin, Y., Peehl, D.M., Fung, K.M., and Lin, H.K.(2006). Aldo-keto reductase (AKR) 1C3: role in prostate disease and the development of specific inhibitors. Mol. Cell Endocrinol.248, 182\u2013191.", "journal-title": "Mol. Cell Endocrinol."}, {"key": "5_CR53_5", "doi-asserted-by": "publisher", "first-page": "7856", "DOI": "10.1021/bi982838t", "volume": "38", "author": "K. Ratnam", "year": "1999", "unstructured": "Ratnam, K., Ma, H., and Penning, T.M.(1999). The arginine 276 anchor for NADP(H) dictates fluorescence kinetic transients in 3 alpha-hydroxysteroid dehydrogenase, a representative aldo-keto reductase. Biochemistry38, 7856\u20137864.", "journal-title": "Biochemistry"}, {"key": "5_CR54_5", "doi-asserted-by": "publisher", "first-page": "2922", "DOI": "10.1210/en.2002-0032", "volume": "144", "author": "T.L. Rizner", "year": "2003", "unstructured": "Rizner, T.L., Lin, H.K., Peehl, D.M., Steckelbroeck, S., Bauman, D.R., and Penning, T.M.(2003). Human type 3 3alpha-hydroxysteroid dehydrogenase (aldo-keto reductase 1C2) and androgen metabolism in prostate cells. Endocrinology144, 2922\u20132932.", "journal-title": "Endocrinology"}, {"key": "5_CR55_5", "doi-asserted-by": "publisher", "first-page": "25", "DOI": "10.1146/annurev.bi.63.070194.000325", "volume": "63", "author": "D.W. Russell", "year": "1994", "unstructured": "Russell, D.W. and Wilson, J.D.(1994). Steroid 5 alpha-reductase: two genes/two enzymes. Annu. Rev. Biochem.63, 25\u201361.", "journal-title": "Annu. Rev. Biochem."}, {"key": "5_CR56_5", "doi-asserted-by": "crossref", "first-page": "2928", "DOI": "10.1200/JCO.1997.15.8.2928", "volume": "15", "author": "H.I. Scher", "year": "1997", "unstructured": "Scher, H.I., Liebertz, C., Kelly, W.K., Mazumdar, M., Brett, C., Schwartz, L., Kolvenbag, G., Shapiro, L., and Schwartz, M.(1997). Bicalutamide for advanced prostate cancer: the natural versus treated history of disease. J. Clin. Oncol.15, 2928\u20132938.", "journal-title": "J. Clin. Oncol."}, {"key": "5_CR57_5", "doi-asserted-by": "publisher", "first-page": "601", "DOI": "10.1016/S1097-2765(02)00471-9", "volume": "9", "author": "Y. Shang", "year": "2002", "unstructured": "Shang, Y., Myers, M., and Brown, M.(2002). Formation of the androgen receptor transcription complex. Mol. Cell9, 601\u2013610.", "journal-title": "Mol. Cell"}, {"key": "5_CR58_5", "doi-asserted-by": "publisher", "first-page": "525", "DOI": "10.1210/er.2002-0050", "volume": "26", "author": "J. Simard", "year": "2005", "unstructured": "Simard, J., Ricketts, M.L., Gingras, S., Soucy, P., Feltus, F.A., and Melner, M.H.(2005). Molecular biology of the 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase gene family. Endocr. Rev.26, 525\u2013582.", "journal-title": "Endocr. Rev."}, {"key": "5_CR59_5", "doi-asserted-by": "publisher", "first-page": "855", "DOI": "10.1210/jc.86.2.855", "volume": "86", "author": "T.G. Soderstrom", "year": "2001", "unstructured": "Soderstrom, T.G., Bjelfman, C., Brekkan, E., Ask, B., Egevad, L., Norlen, B.J., and Rane, A.(2001). Messenger ribonucleic acid levels of steroid 5 alpha-reductase 2 in human prostate predict the enzyme activity. J. Clin. Endocrinol. Metab.86, 855\u2013858.", "journal-title": "J. Clin. Endocrinol. Metab."}, {"key": "5_CR60_5", "doi-asserted-by": "publisher", "first-page": "2815", "DOI": "10.1158/0008-5472.CAN-05-4000", "volume": "66", "author": "M. Stanbrough", "year": "2006", "unstructured": "Stanbrough, M., Bubley, G.J., Ross, K., Golub, T.R., Rubin, M.A., Penning, T.M., Febbo, P.G., and Balk, S.P.(2006). Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer. Cancer Res.66, 2815\u20132825.", "journal-title": "Cancer Res."}, {"key": "5_CR61_5", "doi-asserted-by": "publisher", "first-page": "10784", "DOI": "10.1074/jbc.M313308200", "volume": "279", "author": "S. Steckelbroeck", "year": "2004", "unstructured": "Steckelbroeck, S., Jin, Y., Gopishetty, S., Oyesanmi, B., and Penning, T.M.(2004). Human cytosolic 3alpha-hydroxysteroid dehydrogenases of the aldo-keto reductase superfamily display significant 3beta-hydroxysteroid dehydrogenase activity: implications for steroid hormone metabolism and action. J. Biol. Chem.279, 10784\u201310795.", "journal-title": "J. Biol. Chem."}, {"key": "5_CR62_5", "doi-asserted-by": "publisher", "first-page": "12975", "DOI": "10.1073/pnas.94.24.12975", "volume": "94", "author": "J.V. Swinnen", "year": "1997", "unstructured": "Swinnen, J.V., Ulrix, W., Heyns, W., and Verhoeven, G.(1997). Coordinate regulation of lipogenic gene expression by androgens: evidence for a cascade mechanism involving sterol regulatory element binding proteins. Proc. Natl. Acad. Sci. U. S. A94, 12975\u201312980.", "journal-title": "Proc. Natl. Acad. Sci. U. S. A"}, {"key": "5_CR63_5", "doi-asserted-by": "publisher", "first-page": "2019", "DOI": "10.1097/01.ju.0000091804.20183.81", "volume": "170", "author": "L.N. Thomas", "year": "2003", "unstructured": "Thomas, L.N., Douglas, R.C., Vessey, J.P., Gupta, R., Fontaine, D., Norman, R.W., Thompson, I.M., Troyer, D.A., Rittmaster, R.S., and Lazier, C.B.(2003). 5alpha-reductase type 1 immunostaining is enhanced in some prostate cancers compared with benign prostatic hyperplasia epithelium. J. Urol.170, 2019\u20132025.", "journal-title": "J. Urol."}, {"key": "5_CR64_5", "doi-asserted-by": "publisher", "first-page": "231", "DOI": "10.1002/pros.20188", "volume": "63", "author": "L.N. Thomas", "year": "2005", "unstructured": "Thomas, L.N., Lazier, C.B., Gupta, R., Norman, R.W., Troyer, D.A., O'Brien, S.P., and Rittmaster, R.S.(2005). Differential alterations in 5alpha-reductase type 1 and type 2 levels during development and progression of prostate cancer. Prostate63, 231\u2013239.", "journal-title": "Prostate"}, {"key": "5_CR65_5", "doi-asserted-by": "publisher", "first-page": "244", "DOI": "10.1016/j.eururo.2007.10.052", "volume": "53", "author": "L.N. Thomas", "year": "2007", "unstructured": "Thomas, L.N., Douglas, R.C., Lazier, C.B., Too, C.K., Rittmaster, R.S., and Tindall, D.J.(2007). Type 1 and Type 2 5alpha-reductase expression in the development and progression of prostate cancer. Eur. Urol.53, 244-252.", "journal-title": "Eur. Urol."}, {"key": "5_CR66_5", "doi-asserted-by": "publisher", "first-page": "215", "DOI": "10.1056/NEJMoa030660", "volume": "349", "author": "I.M. Thompson", "year": "2003", "unstructured": "Thompson, I.M., Goodman, P.J., Tangen, C.M., Lucia, M.S., Miller, G.J., Ford, L.G., Lieber, M.M., Cespedes, R.D., Atkins, J.N., Lippman, S.M., Carlin, S.M., Ryan, A., Szczepanek, C.M., Crowley, J.J., and Coltman, C.A., Jr.(2003). The influence of finasteride on the development of prostate cancer. N. Engl. J. Med.349, 215\u2013224.", "journal-title": "N. Engl. J. Med."}, {"key": "5_CR67_5", "doi-asserted-by": "publisher", "first-page": "4365", "DOI": "10.1158/1078-0432.CCR-04-0738", "volume": "11", "author": "M.A. Titus", "year": "2005a", "unstructured": "Titus, M.A., Gregory, C.W., Ford, O.H., III, Schell, M.J., Maygarden, S.J., and Mohler, J.L.(2005a). Steroid 5alpha-reductase isozymes I and II in recurrent prostate cancer. Clin. Cancer Res.11, 4365\u20134371.", "journal-title": "Clin. Cancer Res."}, {"key": "5_CR68_5", "doi-asserted-by": "publisher", "first-page": "4653", "DOI": "10.1158/1078-0432.CCR-05-0525", "volume": "11", "author": "M.A. Titus", "year": "2005b", "unstructured": "Titus, M.A., Schell, M.J., Lih, F.B., Tomer, K.B., and Mohler, J.L.(2005b). Testosterone and dihydrotestosterone tissue levels in recurrent prostate cancer. Clin. Cancer Res.11, 4653\u20134657.", "journal-title": "Clin. Cancer Res."}, {"key": "5_CR69_5", "doi-asserted-by": "publisher", "first-page": "13589", "DOI": "10.1073/pnas.162477299", "volume": "99", "author": "Z. Weihua", "year": "2002", "unstructured": "Weihua, Z., Lathe, R., Warner, M., and Gustafsson, J.A.(2002). An endocrine pathway in the prostate, ERbeta, AR, 5alpha-androstane-3beta,17beta-diol, and CYP7B1, regulates prostate growth. Proc. Natl. Acad. Sci. U. S. A99, 13589\u201313594.", "journal-title": "Proc. Natl. Acad. Sci. U. S. A"}, {"key": "5_CR70_5", "doi-asserted-by": "publisher", "first-page": "6330", "DOI": "10.1073/pnas.111150898", "volume": "98", "author": "Z. Weihua", "year": "2001", "unstructured": "Weihua, Z., Makela, S., Andersson, L.C., Salmi, S., Saji, S., Webster, J.I., Jensen, E.V., Nilsson, S., Warner, M., and Gustafsson, J.A.(2001). A role for estrogen receptor beta in the regulation of growth of the ventral prostate. Proc. Natl. Acad. Sci. U. S. A98, 6330\u20136335.", "journal-title": "Proc. Natl. Acad. Sci. U. S. A"}, {"key": "5_CR71_5", "first-page": "577", "volume": "14", "author": "J.D. Wilson", "year": "1993", "unstructured": "Wilson, J.D., Griffin, J.E., and Russell, D.W.(1993). Steroid 5 alpha-reductase 2 deficiency. Endocr. Rev.14, 577\u2013593.", "journal-title": "Endocr. Rev."}, {"key": "5_CR72_5", "doi-asserted-by": "publisher", "first-page": "615", "DOI": "10.1016/j.cell.2005.12.032", "volume": "124", "author": "P. Zhu", "year": "2006", "unstructured": "Zhu, P., Baek, S.H., Bourk, E.M., Ohgi, K.A., Garcia-Bassets, I., Sanjo, H., Akira, S., Kotol, P.F., Glass, C.K., Rosenfeld, M.G., and Rose, D.W.(2006). Macrophage/Cancer cell interactions mediate hormone resistance by a nuclear receptor derepression pathway. Cell124, 615\u2013629.", "journal-title": "Cell"}], "container-title": ["Androgen Action in Prostate Cancer"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/978-0-387-69179-4_5", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 10, 9]], "date-time": "2018-10-09T02:38:56Z", "timestamp": 1539052736000}, "score": 45.20563, "issued": {"date-parts": [[2009]]}, "ISBN": ["9780387691770", "9780387691794"], "references-count": 72, "URL": "http://dx.doi.org/10.1007/978-0-387-69179-4_5", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T06:07:20Z", "timestamp": 1574230040367}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "14", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2006, 9, 1]], "date-time": "2006-09-01T00:00:00Z", "timestamp": 1157068800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["European Urology Supplements"], "published-print": {"date-parts": [[2006, 9]]}, "DOI": "10.1016/s1569-9056(06)61333-x", "type": "journal-article", "created": {"date-parts": [[2006, 9, 19]], "date-time": "2006-09-19T16:09:23Z", "timestamp": 1158682163000}, "page": "807", "source": "Crossref", "is-referenced-by-count": 0, "title": ["ANDROGEN RECEPTOR REMAINS ESSENTIAL FOR PROSTATE CANCER CELL LINE GROWTH IN ANDROGEN DEPLETED CONDITION"], "prefix": "10.1016", "volume": "5", "author": [{"given": "N.", "family": "Dizeyi", "sequence": "first", "affiliation": []}, {"given": "T.", "family": "Zhang", "sequence": "additional", "affiliation": []}, {"given": "H.", "family": "Wang", "sequence": "additional", "affiliation": []}, {"given": "S.P.", "family": "Balk", "sequence": "additional", "affiliation": []}, {"given": "X.", "family": "Yan", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["European Urology Supplements"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S156990560661333X?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S156990560661333X?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 1, 13]], "date-time": "2019-01-13T03:22:45Z", "timestamp": 1547349765000}, "score": 44.60949, "issued": {"date-parts": [[2006, 9]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2006, 9]]}, "issue": "14"}, "alternative-id": ["S156990560661333X"], "URL": "http://dx.doi.org/10.1016/s1569-9056(06)61333-x", "ISSN": ["1569-9056"], "issn-type": [{"value": "1569-9056", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T23:10:15Z", "timestamp": 1574464215265}, "publisher-location": "New York, NY", "reference-count": 94, "publisher": "Springer New York", "isbn-type": [{"value": "9781603278317", "type": "print"}, {"value": "9781603278294", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2010]]}, "DOI": "10.1007/978-1-60327-829-4_6", "type": "book-chapter", "created": {"date-parts": [[2010, 9, 13]], "date-time": "2010-09-13T18:40:40Z", "timestamp": 1284403240000}, "page": "71-81", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Androgen Receptor Antagonists"], "prefix": "10.1007", "author": [{"given": "Howard C.", "family": "Shen", "sequence": "first", "affiliation": []}, {"given": "Mary-Ellen", "family": "Taplin", "sequence": "additional", "affiliation": []}, {"given": "Steven P.", "family": "Balk", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2010, 8, 3]]}, "reference": [{"issue": "2", "key": "6_CR1_6", "doi-asserted-by": "crossref", "first-page": "180", "DOI": "10.1016/S0022-5347(17)55844-9", "volume": "123", "author": "K Isurugi", "year": "1980", "unstructured": "Isurugi K, Fukutani K, Ishida H, Hosoi Y. Endocrine effects of cyproterone acetate in patients with prostatic cancer. J Urol 1980; 123(2):180\u2013183.", "journal-title": "J Urol"}, {"issue": "2", "key": "6_CR2_6", "first-page": "968", "volume": "267", "author": "JA Kemppainen", "year": "1992", "unstructured": "Kemppainen JA, Lane MV, Sar M, Wilson EM. Androgen receptor phosphorylation, turnover, nuclear transport, and transcriptional activation. Specificity for steroids and antihormones. J Biol Chem 1992; 267(2):968\u2013974.", "journal-title": "J Biol Chem"}, {"issue": "8", "key": "6_CR3_6", "doi-asserted-by": "publisher", "first-page": "1641", "DOI": "10.1007/s11095-006-9024-3", "volume": "23", "author": "W Gao", "year": "2006", "unstructured": "Gao W, Kim J, Dalton JT. Pharmacokinetics and pharmacodynamics of nonsteroidal androgen receptor ligands. Pharm Res 2006; 23(8):1641\u20131658.", "journal-title": "Pharm Res"}, {"issue": "1", "key": "6_CR4_6", "doi-asserted-by": "publisher", "first-page": "211", "DOI": "10.1124/mol.63.1.211", "volume": "63", "author": "D Yin", "year": "2003", "unstructured": "Yin D, He Y, Perera MA, Hong SS, Marhefka C, Stourman N et al. Key structural features of nonsteroidal ligands for binding and activation of the androgen receptor. Mol Pharmacol 2003; 63(1):211\u2013223.", "journal-title": "Mol Pharmacol"}, {"issue": "6", "key": "6_CR5_6", "doi-asserted-by": "publisher", "first-page": "633", "DOI": "10.1007/BF00615229", "volume": "34", "author": "M Schulz", "year": "1988", "unstructured": "Schulz M, Schmoldt A, Donn F, Becker H. The pharmacokinetics of flutamide and its major metabolites after a single oral dose and during chronic treatment. Eur J Clin Pharmacol 1988; 34(6):633\u2013636.", "journal-title": "Eur J Clin Pharmacol"}, {"issue": "Suppl 2", "key": "6_CR6_6", "doi-asserted-by": "publisher", "first-page": "13", "DOI": "10.1016/0090-4295(91)80096-P", "volume": "37", "author": "PJ Creaven", "year": "1991", "unstructured": "Creaven PJ, Pendyala L, Tremblay D. Pharmacokinetics and metabolism of nilutamide. Urology 1991; 37(Suppl 2):13\u201319.", "journal-title": "Urology"}, {"issue": "1", "key": "6_CR7_6", "doi-asserted-by": "crossref", "first-page": "77", "DOI": "10.1016/S0022-5347(17)36003-2", "volume": "149", "author": "RA Janknegt", "year": "1993", "unstructured": "Janknegt RA, Abbou CC, Bartoletti R, Bernstein-Hahn L, Bracken B, Brisset JM et al. Orchiectomy and nilutamide or placebo as treatment of metastatic prostatic cancer in a multinational double-blind randomized trial. J Urol 1993; 149(1):77\u201382.", "journal-title": "J Urol"}, {"issue": "2", "key": "6_CR8_6", "doi-asserted-by": "publisher", "first-page": "117", "DOI": "10.3109/00498259609046693", "volume": "26", "author": "A Mukherjee", "year": "1996", "unstructured": "Mukherjee A, Kirkovsky L, Yao XT, Yates RC, Miller DD, Dalton JT. Enantioselective binding of Casodex to the androgen receptor. Xenobiotica 1996; 26(2):117\u2013122.", "journal-title": "Xenobiotica"}, {"issue": "Suppl 1A", "key": "6_CR9_6", "doi-asserted-by": "publisher", "first-page": "13", "DOI": "10.1016/S0090-4295(96)80003-3", "volume": "47", "author": "BJ Furr", "year": "1996", "unstructured": "Furr BJ, Tucker H. The preclinical development of bicalutamide: pharmacodynamics and mechanism of action. Urology 1996; 47(Suppl 1A):13\u201325.", "journal-title": "Urology"}, {"issue": "29", "key": "6_CR10_6", "doi-asserted-by": "publisher", "first-page": "26321", "DOI": "10.1074/jbc.M203310200", "volume": "277", "author": "D Masiello", "year": "2002", "unstructured": "Masiello D, Cheng S, Bubley GJ, Lu ML, Balk SP. Bicalutamide functions as an androgen receptor antagonist by assembly of a transcriptionally inactive receptor. J Biol Chem 2002; 277(29):26321\u201326326.", "journal-title": "J Biol Chem"}, {"issue": "13", "key": "6_CR11_6", "doi-asserted-by": "publisher", "first-page": "3001", "DOI": "10.1200/JCO.2002.10.018", "volume": "20", "author": "EP Gelmann", "year": "2002", "unstructured": "Gelmann EP. Molecular biology of the androgen receptor. J Clin Oncol 2002; 20(13):3001\u20133015.", "journal-title": "J Clin Oncol"}, {"issue": "3", "key": "6_CR12_6", "doi-asserted-by": "publisher", "first-page": "425", "DOI": "10.1016/j.molcel.2004.09.036", "volume": "16", "author": "B He", "year": "2004", "unstructured": "He B, Gampe RT, Jr., Kole AJ, Hnat AT, Stanley TB, An G et al. Structural basis for androgen receptor interdomain and coactivator interactions suggests a transition in nuclear receptor activation function dominance. Mol Cell 2004; 16(3):425\u2013438.", "journal-title": "Mol Cell"}, {"issue": "9", "key": "6_CR13_6", "doi-asserted-by": "publisher", "first-page": "E274", "DOI": "10.1371/journal.pbio.0020274", "volume": "2", "author": "E Hur", "year": "2004", "unstructured": "Hur E, Pfaff SJ, Payne ES, Gron H, Buehrer BM, Fletterick RJ. Recognition and accommodation at the androgen receptor coactivator binding interface. PLoS Biol 2004; 2(9):E274.", "journal-title": "PLoS Biol"}, {"issue": "9", "key": "6_CR14_6", "doi-asserted-by": "publisher", "first-page": "8060", "DOI": "10.1074/jbc.M407046200", "volume": "280", "author": "E Estebanez-Perpina", "year": "2005", "unstructured": "Estebanez-Perpina E, Moore JM, Mar E, Delgado-Rodrigues E, Nguyen P, Baxter JD et al. The molecular mechanisms of coactivator utilization in ligand-dependent transactivation by the androgen receptor. J Biol Chem 2005; 280(9):8060\u20138068.", "journal-title": "J Biol Chem"}, {"issue": "30", "key": "6_CR15_6", "doi-asserted-by": "publisher", "first-page": "22986", "DOI": "10.1074/jbc.M002807200", "volume": "275", "author": "B He", "year": "2000", "unstructured": "He B, Kemppainen JA, Wilson EM. FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand binding domain of the androgen receptor. J Biol Chem 2000; 275(30):22986\u201322994.", "journal-title": "J Biol Chem"}, {"issue": "34", "key": "6_CR16_6", "doi-asserted-by": "publisher", "first-page": "26164", "DOI": "10.1074/jbc.M004571200", "volume": "275", "author": "PM Matias", "year": "2000", "unstructured": "Matias PM, Donner P, Coelho R, Thomaz M, Peixoto C, Macedo S et al. Structural evidence for ligand specificity in the binding domain of the human androgen receptor. Implications for pathogenic gene mutations. J Biol Chem 2000; 275(34):26164\u201326171.", "journal-title": "J Biol Chem"}, {"issue": "9", "key": "6_CR17_6", "doi-asserted-by": "publisher", "first-page": "4904", "DOI": "10.1073/pnas.081565498", "volume": "98", "author": "JS Sack", "year": "2001", "unstructured": "Sack JS, Kish KF, Wang C, Attar RM, Kiefer SE, An Y et al. Crystallographic structures of the ligand-binding domains of the androgen receptor and its T877A mutant complexed with the natural agonist dihydrotestosterone. Proc Natl Acad Sci U S A 2001; 98(9):4904\u20134909.", "journal-title": "Proc Natl Acad Sci U S A"}, {"issue": "11", "key": "6_CR18_6", "doi-asserted-by": "publisher", "first-page": "1729", "DOI": "10.1021/jm0005353", "volume": "44", "author": "CA Marhefka", "year": "2001", "unstructured": "Marhefka CA, Moore BM, Bishop TC, Kirkovsky L, Mukherjee A, Dalton JT et al. Homology modeling using multiple molecular dynamics simulations and docking studies of the human androgen receptor ligand binding domain bound to testosterone and nonsteroidal ligands. J Med Chem 2001; 44(11):1729\u20131740.", "journal-title": "J Med Chem"}, {"issue": "45", "key": "6_CR19_6", "doi-asserted-by": "publisher", "first-page": "37747", "DOI": "10.1074/jbc.M507464200", "volume": "280", "author": "CE Bohl", "year": "2005", "unstructured": "Bohl CE, Miller DD, Chen J, Bell CE, Dalton JT. Structural basis for accommodation of nonsteroidal ligands in the androgen receptor. J Biol Chem 2005; 280(45):37747\u201337754.", "journal-title": "J Biol Chem"}, {"issue": "18", "key": "6_CR20_6", "doi-asserted-by": "publisher", "first-page": "13648", "DOI": "10.1074/jbc.M611711200", "volume": "282", "author": "CE Bohl", "year": "2007", "unstructured": "Bohl CE, Wu Z, Miller DD, Bell CE, Dalton JT. Crystal structure of the T877A human androgen receptor ligand-binding domain complexed to cyproterone acetate provides insight for ligand-induced conformational changes and structure-based drug design. J Biol Chem 2007; 282(18):13648\u201313655.", "journal-title": "J Biol Chem"}, {"issue": "11", "key": "6_CR21_6", "first-page": "2511", "volume": "59", "author": "ME Taplin", "year": "1999", "unstructured": "Taplin ME, Bubley GJ, Ko YJ, Small EJ, Upton M, Rajeshkumar B et al. Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist. Cancer Res 1999; 59(11):2511\u20132515.", "journal-title": "Cancer Res"}, {"issue": "14", "key": "6_CR22_6", "doi-asserted-by": "publisher", "first-page": "2673", "DOI": "10.1200/JCO.2003.11.102", "volume": "21", "author": "ME Taplin", "year": "2003", "unstructured": "Taplin ME, Rajeshkumar B, Halabi S, Werner CP, Woda BA, Picus J et al. Androgen receptor mutations in androgen-independent prostate cancer: Cancer and Leukemia Group B Study 9663. J Clin Oncol 2003; 21(14):2673\u20132678.", "journal-title": "J Clin Oncol"}, {"issue": "1", "key": "6_CR23_6", "first-page": "149", "volume": "63", "author": "T Hara", "year": "2003", "unstructured": "Hara T, Miyazaki J, Araki H, Yamaoka M, Kanzaki N, Kusaka M et al. Novel mutations of androgen receptor: a possible mechanism of bicalutamide withdrawal syndrome. Cancer Res 2003; 63(1):149\u2013153.", "journal-title": "Cancer Res"}, {"issue": "17", "key": "6_CR24_6", "doi-asserted-by": "publisher", "first-page": "6201", "DOI": "10.1073/pnas.0500381102", "volume": "102", "author": "CE Bohl", "year": "2005", "unstructured": "Bohl CE, Gao W, Miller DD, Bell CE, Dalton JT. Structural basis for antagonism and resistance of bicalutamide in prostate cancer. Proc Natl Acad Sci U S A 2005; 102(17):6201\u20136206.", "journal-title": "Proc Natl Acad Sci U S A"}, {"issue": "6652", "key": "6_CR25_6", "doi-asserted-by": "publisher", "first-page": "753", "DOI": "10.1038/39645", "volume": "389", "author": "AM Brzozowski", "year": "1997", "unstructured": "Brzozowski AM, Pike AC, Dauter Z, Hubbard RE, Bonn T, Engstrom O et al. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 1997; 389(6652):753\u2013758.", "journal-title": "Nature"}, {"issue": "7", "key": "6_CR26_6", "doi-asserted-by": "publisher", "first-page": "927", "DOI": "10.1016/S0092-8674(00)81717-1", "volume": "95", "author": "AK Shiau", "year": "1998", "unstructured": "Shiau AK, Barstad D, Loria PM, Cheng L, Kushner PJ, Agard DA et al. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 1998; 95(7):927\u2013937.", "journal-title": "Cell"}, {"key": "6_CR27_6", "doi-asserted-by": "publisher", "first-page": "129", "DOI": "10.1146/annurev.med.48.1.129", "volume": "48", "author": "F Cadepond", "year": "1997", "unstructured": "Cadepond F, Ulmann A, Baulieu EE. RU486 (mifepristone): mechanisms of action and clinical uses. Annu Rev Med 1997; 48:129\u2013156.", "journal-title": "Annu Rev Med"}, {"issue": "42", "key": "6_CR28_6", "doi-asserted-by": "publisher", "first-page": "30910", "DOI": "10.1074/jbc.M705524200", "volume": "282", "author": "L Cantin", "year": "2007", "unstructured": "Cantin L, Faucher F, Couture JF, Jesus-Tran KP, Legrand P, Ciobanu LC et al. Structural characterization of the human androgen receptor ligand-binding domain complexed with EM5744, a rationally designed steroidal ligand bearing a bulky chain directed toward helix 12. J Biol Chem 2007; 282(42):30910\u201330919.", "journal-title": "J Biol Chem"}, {"issue": "5564", "key": "6_CR29_6", "doi-asserted-by": "publisher", "first-page": "2465", "DOI": "10.1126/science.1068537", "volume": "295", "author": "Y Shang", "year": "2002", "unstructured": "Shang Y, Brown M. Molecular determinants for the tissue specificity of SERMs. Science 2002; 295(5564):2465\u20132468.", "journal-title": "Science"}, {"issue": "6", "key": "6_CR30_6", "doi-asserted-by": "publisher", "first-page": "693", "DOI": "10.1210/me.11.6.693", "volume": "11", "author": "TA Jackson", "year": "1997", "unstructured": "Jackson TA, Richer JK, Bain DL, Takimoto GS, Tung L, Horwitz KB. The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT. Mol Endocrinol 1997; 11(6):693\u2013705.", "journal-title": "Mol Endocrinol"}, {"issue": "29", "key": "6_CR31_6", "doi-asserted-by": "publisher", "first-page": "26238", "DOI": "10.1074/jbc.M203268200", "volume": "277", "author": "M Schulz", "year": "2002", "unstructured": "Schulz M, Eggert M, Baniahmad A, Dostert A, Heinzel T, Renkawitz R. RU486-induced glucocorticoid receptor agonism is controlled by the receptor N terminus and by corepressor binding. J Biol Chem 2002; 277(29):26238\u201326243.", "journal-title": "J Biol Chem"}, {"issue": "3", "key": "6_CR32_6", "doi-asserted-by": "crossref", "first-page": "1369", "DOI": "10.1128/MCB.18.3.1369", "volume": "18", "author": "BL Wagner", "year": "1998", "unstructured": "Wagner BL, Norris JD, Knotts TA, Weigel NL, McDonnell DP. The nuclear corepressors NCoR and SMRT are key regulators of both ligand- and 8-bromo-cyclic AMP-dependent transcriptional activity of the human progesterone receptor. Mol Cell Biol 1998; 18(3):1369\u20131378.", "journal-title": "Mol Cell Biol"}, {"issue": "1", "key": "6_CR33_6", "doi-asserted-by": "publisher", "first-page": "70", "DOI": "10.1210/me.2003-0189", "volume": "18", "author": "LN Song", "year": "2004", "unstructured": "Song LN, Coghlan M, Gelmann EP. Antiandrogen effects of mifepristone on coactivator and corepressor interactions with the androgen receptor. Mol Endocrinol 2004; 18(1):70\u201385.", "journal-title": "Mol Endocrinol"}, {"issue": "8", "key": "6_CR34_6", "doi-asserted-by": "publisher", "first-page": "6511", "DOI": "10.1074/jbc.M408972200", "volume": "280", "author": "MC Hodgson", "year": "2005", "unstructured": "Hodgson MC, Astapova I, Cheng S, Lee LJ, Verhoeven MC, Choi E et al. The androgen receptor recruits nuclear receptor CoRepressor (N-CoR) in the presence of mifepristone via its N and C termini revealing a novel molecular mechanism for androgen receptor antagonists. J Biol Chem 2005; 280(8):6511\u20136519.", "journal-title": "J Biol Chem"}, {"issue": "7", "key": "6_CR35_6", "doi-asserted-by": "publisher", "first-page": "1492", "DOI": "10.1210/me.16.7.1492", "volume": "16", "author": "S Cheng", "year": "2002", "unstructured": "Cheng S, Brzostek S, Lee SR, Hollenberg AN, Balk SP. Inhibition of the dihydrotestosterone-activated androgen receptor by nuclear receptor corepressor. Mol Endocrinol 2002; 16(7):1492\u20131501.", "journal-title": "Mol Endocrinol"}, {"issue": "4", "key": "6_CR36_6", "doi-asserted-by": "publisher", "first-page": "661", "DOI": "10.1210/me.16.4.661", "volume": "16", "author": "H Dotzlaw", "year": "2002", "unstructured": "Dotzlaw H, Moehren U, Mink S, Cato AC, Iniguez Lluhi JA, Baniahmad A. The amino terminus of the human AR is target for corepressor action and antihormone agonism. Mol Endocrinol 2002; 16(4):661\u2013673.", "journal-title": "Mol Endocrinol"}, {"issue": "7", "key": "6_CR37_6", "doi-asserted-by": "publisher", "first-page": "5052", "DOI": "10.1074/jbc.M206374200", "volume": "278", "author": "G Liao", "year": "2003", "unstructured": "Liao G, Chen LY, Zhang A, Godavarthy A, Xia F, Ghosh JC et al. Regulation of androgen receptor activity by the nuclear receptor corepressor SMRT. J Biol Chem 2003; 278(7):5052\u20135061.", "journal-title": "J Biol Chem"}, {"issue": "1", "key": "6_CR38_6", "doi-asserted-by": "publisher", "first-page": "79", "DOI": "10.1016/j.mce.2003.10.036", "volume": "213", "author": "H Dotzlaw", "year": "2003", "unstructured": "Dotzlaw H, Papaioannou M, Moehren U, Claessens F, Baniahmad A. Agonist-antagonist induced coactivator and corepressor interplay on the human androgen receptor. Mol Cell Endocrinol 2003; 213(1):79\u201385.", "journal-title": "Mol Cell Endocrinol"}, {"issue": "17", "key": "6_CR39_6", "doi-asserted-by": "publisher", "first-page": "6633", "DOI": "10.1128/MCB.01534-05", "volume": "26", "author": "Y Wu", "year": "2006", "unstructured": "Wu Y, Kawate H, Ohnaka K, Nawata H, Takayanagi R. Nuclear compartmentalization of N-CoR and its interactions with steroid receptors. Mol Cell Biol 2006; 26(17):6633\u20136655.", "journal-title": "Mol Cell Biol"}, {"issue": "20", "key": "6_CR40_6", "first-page": "1048", "volume": "5", "author": "HG Yoon", "year": "2005", "unstructured": "Yoon HG, Wong J. The corepressors SMRT and N-CoR are involved in agonist- and antagonist-regulated transcription by androgen receptor. Mol Endocrinol 2005; 20(5):1048\u20131060.", "journal-title": "Mol Endocrinol"}, {"issue": "17", "key": "6_CR41_6", "doi-asserted-by": "publisher", "first-page": "8388", "DOI": "10.1158/0008-5472.CAN-07-0617", "volume": "67", "author": "MC Hodgson", "year": "2007", "unstructured": "Hodgson MC, Astapova I, Hollenberg AN, Balk SP. Activity of androgen receptor antagonist bicalutamide in prostate cancer cells is independent of NCoR and SMRT corepressors. Cancer Res 2007; 67(17):8388\u20138395.", "journal-title": "Cancer Res"}, {"issue": "3", "key": "6_CR42_6", "doi-asserted-by": "publisher", "first-page": "601", "DOI": "10.1016/S1097-2765(02)00471-9", "volume": "9", "author": "Y Shang", "year": "2002", "unstructured": "Shang Y, Myers M, Brown M. Formation of the androgen receptor transcription complex. Mol Cell 2002; 9(3):601\u2013610.", "journal-title": "Mol Cell"}, {"issue": "11", "key": "6_CR43_6", "doi-asserted-by": "publisher", "first-page": "2633", "DOI": "10.1210/me.2004-0245", "volume": "18", "author": "Z Kang", "year": "2004", "unstructured": "Kang Z, Janne OA, Palvimo JJ. Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor. Mol Endocrinol 2004; 18(11):2633\u20132648.", "journal-title": "Mol Endocrinol"}, {"issue": "Pt 3", "key": "6_CR44_6", "doi-asserted-by": "publisher", "first-page": "731", "DOI": "10.1042/BJ20031456", "volume": "379", "author": "CA Berrevoets", "year": "2004", "unstructured": "Berrevoets CA, Umar A, Trapman J, Brinkmann AO. Differential modulation of androgen receptor transcriptional activity by the nuclear receptor corepressor (N-CoR). Biochem J 2004; 379(Pt 3):731\u2013738.", "journal-title": "Biochem J"}, {"issue": "3", "key": "6_CR45_6", "doi-asserted-by": "publisher", "first-page": "615", "DOI": "10.1016/j.cell.2005.12.032", "volume": "124", "author": "P Zhu", "year": "2006", "unstructured": "Zhu P, Baek SH, Bourk EM, Ohgi KA, Garcia-Bassets I, Sanjo H et al. Macrophage/cancer cell interactions mediate hormone resistance by a nuclear receptor derepression pathway. Cell 2006; 124(3):615\u2013629.", "journal-title": "Cell"}, {"issue": "5", "key": "6_CR46_6", "doi-asserted-by": "publisher", "first-page": "447", "DOI": "10.1159/000019634", "volume": "33", "author": "CJ Tyrrell", "year": "1998", "unstructured": "Tyrrell CJ, Kaisary AV, Iversen P, Anderson JB, Baert L, Tammela T et al. A randomised comparison of \u2018Casodex\u2019 (bicalutamide) 150 mg monotherapy versus castration in the treatment of metastatic and locally advanced prostate cancer. Eur Urol 1998; 33(5):447\u2013456.", "journal-title": "Eur Urol"}, {"issue": "5", "key": "6_CR47_6", "doi-asserted-by": "publisher", "first-page": "1579", "DOI": "10.1016/S0022-5347(05)67032-2", "volume": "164", "author": "P Iversen", "year": "2000", "unstructured": "Iversen P, Tyrrell CJ, Kaisary AV, Anderson JB, van Poppel H, Tammela TL et al. Bicalutamide monotherapy compared with castration in patients with nonmetastatic locally advanced prostate cancer: 6.3 years of followup. J Urol 2000; 164(5):1579\u20131582.", "journal-title": "J Urol"}, {"issue": "3", "key": "6_CR48_6", "doi-asserted-by": "publisher", "first-page": "389", "DOI": "10.1016/S0090-4295(98)00004-1", "volume": "51", "author": "P Iversen", "year": "1998", "unstructured": "Iversen P, Tyrrell CJ, Kaisary AV, Anderson JB, Baert L, Tammela T et al. Casodex (bicalutamide) 150-mg monotherapy compared with castration in patients with previously untreated nonmetastatic prostate cancer: results from two multicenter randomized trials at a median follow-up of 4 years. Urology 1998; 51(3):389\u2013396.", "journal-title": "Urology"}, {"issue": "5", "key": "6_CR49_6", "doi-asserted-by": "publisher", "first-page": "481", "DOI": "10.1016/S0302-2838(02)00435-9", "volume": "42", "author": "F Boccardo", "year": "2002", "unstructured": "Boccardo F, Barichello M, Battaglia M, Carmignani G, Comeri G, Ferraris V et al. Bicalutamide monotherapy versus flutamide plus goserelin in prostate cancer: updated results of a multicentric trial. Eur Urol 2002; 42(5):481\u2013490.", "journal-title": "Eur Urol"}, {"issue": "2", "key": "6_CR50_6", "doi-asserted-by": "publisher", "first-page": "247", "DOI": "10.1111/j.1464-410X.2005.06051.x", "volume": "97", "author": "DG McLeod", "year": "2006", "unstructured": "McLeod DG, Iversen P, See WA, Morris T, Armstrong J, Wirth MP. Bicalutamide 150 mg plus standard care vs standard care alone for early prostate cancer. BJU Int 2006; 97(2):247\u2013254.", "journal-title": "BJU Int"}, {"issue": "2", "key": "6_CR51_6", "doi-asserted-by": "publisher", "first-page": "520", "DOI": "10.1016/j.juro.2006.03.057", "volume": "176", "author": "J Yannucci", "year": "2006", "unstructured": "Yannucci J, Manola J, Garnick MB, Bhat G, Bubley GJ. The effect of androgen deprivation therapy on fasting serum lipid and glucose parameters. J Urol 2006; 176(2):520\u2013525.", "journal-title": "J Urol"}, {"issue": "27", "key": "6_CR52_6", "doi-asserted-by": "publisher", "first-page": "4448", "DOI": "10.1200/JCO.2006.06.2497", "volume": "24", "author": "NL Keating", "year": "2006", "unstructured": "Keating NL, O\u2019Malley AJ, Smith MR. Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer. J Clin Oncol 2006; 24(27):4448\u20134456.", "journal-title": "J Clin Oncol"}, {"issue": "6 Pt 1", "key": "6_CR53_6", "doi-asserted-by": "publisher", "first-page": "2272", "DOI": "10.1097/01.ju.0000127738.94221.da", "volume": "171", "author": "PR Sieber", "year": "2004", "unstructured": "Sieber PR, Keiller DL, Kahnoski RJ, Gallo J, McFadden S. Bicalutamide 150 mg maintains bone mineral density during monotherapy for localized or locally advanced prostate cancer. J Urol 2004; 171(6 Pt 1):2272\u20132276, quiz.", "journal-title": "J Urol"}, {"issue": "13", "key": "6_CR54_6", "doi-asserted-by": "publisher", "first-page": "2546", "DOI": "10.1200/JCO.2004.01.174", "volume": "22", "author": "MR Smith", "year": "2004", "unstructured": "Smith MR, Goode M, Zietman AL, McGovern FJ, Lee H, Finkelstein JS. Bicalutamide monotherapy versus leuprolide monotherapy for prostate cancer: effects on bone mineral density and body composition. J Clin Oncol 2004; 22(13):2546\u20132553.", "journal-title": "J Clin Oncol"}, {"issue": "15", "key": "6_CR55_6", "doi-asserted-by": "publisher", "first-page": "1036", "DOI": "10.1056/NEJM199810083391504", "volume": "339", "author": "MA Eisenberger", "year": "1998", "unstructured": "Eisenberger MA, Blumenstein BA, Crawford ED, Miller G, McLeod DG, Loehrer PJ et al. Bilateral orchiectomy with or without flutamide for metastatic prostate cancer. N Engl J Med 1998; 339(15):1036\u20131042.", "journal-title": "N Engl J Med"}, {"issue": "9214", "key": "6_CR56_6", "doi-asserted-by": "publisher", "first-page": "1491", "DOI": "10.1016/S0140-6736(00)02163-2", "volume": "355", "author": "Prostate Cancer Trialists\u2019 Collaborative Group", "year": "2000", "unstructured": "Prostate Cancer Trialists\u2019 Collaborative Group. Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials. Lancet 2000; 355(9214):1491\u20131498.", "journal-title": "Lancet"}, {"issue": "2 Pt 1", "key": "6_CR57_6", "doi-asserted-by": "crossref", "first-page": "448", "DOI": "10.1016/S0022-5347(01)67071-X", "volume": "154", "author": "JE Fowler Jr", "year": "1995", "unstructured": "Fowler JE, Jr., Pandey P, Seaver LE, Feliz TP. Prostate specific antigen after gonadal androgen withdrawal and deferred flutamide treatment. J Urol 1995; 154(2 Pt 1):448\u2013453.", "journal-title": "J Urol"}, {"issue": "8", "key": "6_CR58_6", "doi-asserted-by": "crossref", "first-page": "2928", "DOI": "10.1200/JCO.1997.15.8.2928", "volume": "15", "author": "HI Scher", "year": "1997", "unstructured": "Scher HI, Liebertz C, Kelly WK, Mazumdar M, Brett C, Schwartz L et al. Bicalutamide for advanced prostate cancer: the natural versus treated history of disease. J Clin Oncol 1997; 15(8):2928\u20132938.", "journal-title": "J Clin Oncol"}, {"issue": "1", "key": "6_CR59_6", "doi-asserted-by": "publisher", "first-page": "149", "DOI": "10.1016/S0022-5347(01)64039-4", "volume": "159", "author": "R Joyce", "year": "1998", "unstructured": "Joyce R, Fenton MA, Rode P, Constantine M, Gaynes L, Kolvenbag G et al. High dose bicalutamide for androgen independent prostate cancer: effect of prior hormonal therapy. J Urol 1998; 159(1):149\u2013153.", "journal-title": "J Urol"}, {"issue": "3", "key": "6_CR60_6", "doi-asserted-by": "crossref", "first-page": "607", "DOI": "10.1016/S0022-5347(17)36163-3", "volume": "149", "author": "WK Kelly", "year": "1993", "unstructured": "Kelly WK, Scher HI. Prostate specific antigen decline after antiandrogen withdrawal: the flutamide withdrawal syndrome. J Urol 1993; 149(3):607\u2013609.", "journal-title": "J Urol"}, {"issue": "3", "key": "6_CR61_6", "doi-asserted-by": "crossref", "first-page": "908", "DOI": "10.1016/S0022-5347(17)35646-X", "volume": "150", "author": "A Dupont", "year": "1993", "unstructured": "Dupont A, Gomez JL, Cusan L, Koutsilieris M, Labrie F. Response to flutamide withdrawal in advanced prostate cancer in progression under combination therapy. J Urol 1993; 150(3):908\u2013913.", "journal-title": "J Urol"}, {"issue": "3", "key": "6_CR62_6", "doi-asserted-by": "publisher", "first-page": "408", "DOI": "10.1016/0090-4295(94)90092-2", "volume": "43", "author": "EJ Small", "year": "1994", "unstructured": "Small EJ, Carroll PR. Prostate-specific antigen decline after casodex withdrawal: evidence for an antiandrogen withdrawal syndrome. Urology 1994; 43(3):408\u2013410.", "journal-title": "Urology"}, {"issue": "3 Pt 2", "key": "6_CR63_6", "first-page": "1070", "volume": "153", "author": "PT Nieh", "year": "1995", "unstructured": "Nieh PT. Withdrawal phenomenon with the antiandrogen casodex. J Urol 1995; 153(3 Pt 2):1070\u20131072.", "journal-title": "J Urol"}, {"issue": "5", "key": "6_CR64_6", "doi-asserted-by": "publisher", "first-page": "1731", "DOI": "10.1016/S0022-5347(01)64846-8", "volume": "157", "author": "PF Schellhammer", "year": "1997", "unstructured": "Schellhammer PF, Venner P, Haas GP, Small EJ, Nieh PT, Seabaugh DR et al. Prostate specific antigen decreases after withdrawal of antiandrogen therapy with bicalutamide or flutamide in patients receiving combined androgen blockade. J Urol 1997; 157(5):1731\u20131735.", "journal-title": "J Urol"}, {"issue": "4", "key": "6_CR65_6", "doi-asserted-by": "publisher", "first-page": "632", "DOI": "10.1016/S0090-4295(96)00558-4", "volume": "49", "author": "SD Huan", "year": "1997", "unstructured": "Huan SD, Gerridzen RG, Yau JC, Stewart DJ. Antiandrogen withdrawal syndrome with nilutamide. Urology 1997; 49(4):632\u2013634.", "journal-title": "Urology"}, {"issue": "11", "key": "6_CR66_6", "doi-asserted-by": "publisher", "first-page": "2393", "DOI": "10.1002/cncr.23473", "volume": "112", "author": "AO Sartor", "year": "2008", "unstructured": "Sartor AO, Tangen CM, Hussain MH, Eisenberger MA, Parab M, Fontana JA et al. Antiandrogen withdrawal in castrate-refractory prostate cancer: a Southwest Oncology Group trial (SWOG 9426). Cancer 2008; 112(11):2393\u20132400.", "journal-title": "Cancer"}, {"issue": "3", "key": "6_CR67_6", "doi-asserted-by": "publisher", "first-page": "222", "DOI": "10.1093/jnci/86.3.222", "volume": "86", "author": "O Sartor", "year": "1994", "unstructured": "Sartor O, Cooper M, Weinberger M, Headlee D, Thibault A, Tompkins A et al. Surprising activity of flutamide withdrawal, when combined with aminoglutethimide, in treatment of \u201chormone-refractory\u201d prostate cancer. J Natl Cancer Inst 1994; 86(3):222\u2013227.", "journal-title": "J Natl Cancer Inst"}, {"issue": "6", "key": "6_CR68_6", "doi-asserted-by": "publisher", "first-page": "1025", "DOI": "10.1200/JCO.2004.06.037", "volume": "22", "author": "EJ Small", "year": "2004", "unstructured": "Small EJ, Halabi S, Dawson NA, Stadler WM, Rini BI, Picus J et al. Antiandrogen withdrawal alone or in combination with ketoconazole in androgen-independent prostate cancer patients: a phase III trial (CALGB 9583). J Clin Oncol 2004; 22(6):1025\u20131033.", "journal-title": "J Clin Oncol"}, {"issue": "2", "key": "6_CR69_6", "doi-asserted-by": "publisher", "first-page": "189", "DOI": "10.1002/ijc.2910480206", "volume": "48", "author": "TH Kwast van der", "year": "1991", "unstructured": "van der Kwast TH, Schalken J, Ruizeveld de Winter JA, van Vroonhoven CC, Mulder E, Boersma W et al. Androgen receptors in endocrine-therapy-resistant human prostate cancer. Int J Cancer 1991; 48(2):189\u2013193.", "journal-title": "Int J Cancer"}, {"issue": "1", "key": "6_CR70_6", "doi-asserted-by": "publisher", "first-page": "217", "DOI": "10.1016/S0002-9440(10)63112-4", "volume": "164", "author": "J Holzbeierlein", "year": "2004", "unstructured": "Holzbeierlein J, Lal P, LaTulippe E, Smith A, Satagopan J, Zhang L et al. Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance. Am J Pathol 2004; 164(1):217\u2013227.", "journal-title": "Am J Pathol"}, {"issue": "2", "key": "6_CR71_6", "doi-asserted-by": "publisher", "first-page": "440", "DOI": "10.1158/1078-0432.CCR-1146-03", "volume": "10", "author": "JL Mohler", "year": "2004", "unstructured": "Mohler JL, Gregory CW, Ford OH, III, Kim D, Weaver CM, Petrusz P et al. The androgen axis in recurrent prostate cancer. Clin Cancer Res 2004; 10(2):440\u2013448.", "journal-title": "Clin Cancer Res"}, {"issue": "5", "key": "6_CR72_6", "doi-asserted-by": "publisher", "first-page": "2815", "DOI": "10.1158/0008-5472.CAN-05-4000", "volume": "66", "author": "M Stanbrough", "year": "2006", "unstructured": "Stanbrough M, Bubley GJ, Ross K, Golub TR, Rubin MA, Penning TM et al. Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer. Cancer Res 2006; 66(5):2815\u20132825.", "journal-title": "Cancer Res"}, {"issue": "11", "key": "6_CR73_6", "doi-asserted-by": "publisher", "first-page": "4447", "DOI": "10.1158/0008-5472.CAN-08-0249", "volume": "68", "author": "RB Montgomery", "year": "2008", "unstructured": "Montgomery RB, Mostaghel EA, Vessella R, Hess DL, Kalhorn TF, Higano CS et al. Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth. Cancer Res 2008; 68(11):4447\u20134454.", "journal-title": "Cancer Res"}, {"issue": "6", "key": "6_CR74_6", "doi-asserted-by": "publisher", "first-page": "783", "DOI": "10.1111/j.1464-410X.2005.05714.x", "volume": "96", "author": "M Nakabayashi", "year": "2005", "unstructured": "Nakabayashi M, Regan MM, Lifsey D, Kantoff PW, Taplin ME, Sartor O et al. Efficacy of nilutamide as secondary hormonal therapy in androgen-independent prostate cancer. BJU Int 2005; 96(6):783\u2013786.", "journal-title": "BJU Int"}, {"issue": "3", "key": "6_CR75_6", "doi-asserted-by": "publisher", "first-page": "921", "DOI": "10.1016/j.juro.2008.05.045", "volume": "180", "author": "H Suzuki", "year": "2008", "unstructured": "Suzuki H, Okihara K, Miyake H, Fujisawa M, Miyoshi S, Matsumoto T et al. Alternative nonsteroidal antiandrogen therapy for advanced prostate cancer that relapsed after initial maximum androgen blockade. J Urol 2008; 180(3):921\u2013927.", "journal-title": "J Urol"}, {"issue": "4", "key": "6_CR76_6", "doi-asserted-by": "publisher", "first-page": "401", "DOI": "10.1038/ng0495-401", "volume": "9", "author": "T Visakorpi", "year": "1995", "unstructured": "Visakorpi T, Hyytinen E, Koivisto P, Tanner M, Keinanen R, Palmberg C et al. In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nat Genet 1995; 9(4):401\u2013406.", "journal-title": "Nat Genet"}, {"issue": "21", "key": "6_CR77_6", "doi-asserted-by": "publisher", "first-page": "1393", "DOI": "10.1056/NEJM199505253322101", "volume": "332", "author": "ME Taplin", "year": "1995", "unstructured": "Taplin ME, Bubley GJ, Shuster TD, Frantz ME, Spooner AE, Ogata GK et al. Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer. N Engl J Med 1995; 332(21):1393\u20131398.", "journal-title": "N Engl J Med"}, {"issue": "1", "key": "6_CR78_6", "doi-asserted-by": "publisher", "first-page": "33", "DOI": "10.1038/nm972", "volume": "10", "author": "CD Chen", "year": "2004", "unstructured": "Chen CD, Welsbie DS, Tran C, Baek SH, Chen R, Vessella R et al. Molecular determinants of resistance to antiandrogen therapy. Nat Med 2004; 10(1):33\u201339.", "journal-title": "Nat Med"}, {"issue": "38", "key": "6_CR79_6", "doi-asserted-by": "publisher", "first-page": "27882", "DOI": "10.1074/jbc.M605002200", "volume": "281", "author": "SM Dehm", "year": "2006", "unstructured": "Dehm SM, Tindall DJ. Ligand-independent androgen receptor activity is activation function-2-independent and resistant to antiandrogens in androgen refractory prostate cancer cells. J Biol Chem 2006; 281(38):27882\u201327893.", "journal-title": "J Biol Chem"}, {"issue": "8", "key": "6_CR80_6", "first-page": "1383", "volume": "3", "author": "MA Fenton", "year": "1997", "unstructured": "Fenton MA, Shuster TD, Fertig AM, Taplin ME, Kolvenbag G, Bubley GJ et al. Functional characterization of mutant androgen receptors from androgen-independent prostate cancer. Clin Cancer Res 1997; 3(8):1383\u20131388.", "journal-title": "Clin Cancer Res"}, {"issue": "4", "key": "6_CR81_6", "doi-asserted-by": "crossref", "first-page": "693", "DOI": "10.1016/S0022-5347(17)49829-6", "volume": "132", "author": "J Geller", "year": "1984", "unstructured": "Geller J, Albert JD, Nachtsheim DA, Loza D. Comparison of prostatic cancer tissue dihydrotestosterone levels at the time of relapse following orchiectomy or estrogen therapy. J Urol 1984; 132(4):693\u2013696.", "journal-title": "J Urol"}, {"issue": "13", "key": "6_CR82_6", "doi-asserted-by": "publisher", "first-page": "4653", "DOI": "10.1158/1078-0432.CCR-05-0525", "volume": "11", "author": "MA Titus", "year": "2005", "unstructured": "Titus MA, Schell MJ, Lih FB, Tomer KB, Mohler JL. Testosterone and dihydrotestosterone tissue levels in recurrent prostate cancer. Clin Cancer Res 2005; 11(13):4653\u20134657.", "journal-title": "Clin Cancer Res"}, {"issue": "6", "key": "6_CR83_6", "doi-asserted-by": "publisher", "first-page": "2212", "DOI": "10.1158/0008-5472.CAN-2148-2", "volume": "64", "author": "SL Ettinger", "year": "2004", "unstructured": "Ettinger SL, Sobel R, Whitmore TG, Akbari M, Bradley DR, Gleave ME et al. Dysregulation of sterol response element-binding proteins and downstream effectors in prostate cancer during progression to androgen independence. Cancer Res 2004; 64(6):2212\u20132221.", "journal-title": "Cancer Res"}, {"issue": "26", "key": "6_CR84_6", "doi-asserted-by": "publisher", "first-page": "4563", "DOI": "10.1200/JCO.2007.15.9749", "volume": "28", "author": "G Attard", "year": "2008", "unstructured": "Attard G, Reid AH, Yap TA, Raynaud F, Dowsett M, Settatree S et al. Phase I clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration-resistant prostate cancer commonly remains hormone driven. J Clin Oncol 2008; 26(28):4563\u20134571.", "journal-title": "J Clin Oncol"}, {"issue": "11", "key": "6_CR85_6", "first-page": "4315", "volume": "61", "author": "CW Gregory", "year": "2001", "unstructured": "Gregory CW, He B, Johnson RT, Ford OH, Mohler JL, French FS et al. A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy. Cancer Res 2001; 61(11):4315\u20134319.", "journal-title": "Cancer Res"}, {"issue": "21", "key": "6_CR86_6", "doi-asserted-by": "publisher", "first-page": "10594", "DOI": "10.1158/0008-5472.CAN-06-1023", "volume": "66", "author": "IU Agoulnik", "year": "2006", "unstructured": "Agoulnik IU, Vaid A, Nakka M, Alvarado M, Bingman WE, III, Erdem H et al. Androgens modulate expression of transcription intermediary factor 2, an androgen receptor coactivator whose expression level correlates with early biochemical recurrence in prostate cancer. Cancer Res 2006; 66(21):10594\u201310602.", "journal-title": "Cancer Res"}, {"issue": "6", "key": "6_CR87_6", "doi-asserted-by": "publisher", "first-page": "1336", "DOI": "10.1093/emboj/cdg120", "volume": "22", "author": "HG Yoon", "year": "2003", "unstructured": "Yoon HG, Chan DW, Huang ZQ, Li J, Fondell JD, Qin J et al. Purification and functional characterization of the human N-CoR complex: the roles of HDAC3, TBL1 and TBLR1. EMBO J 2003; 22(6):1336\u20131346.", "journal-title": "EMBO J"}, {"issue": "9", "key": "6_CR88_6", "first-page": "1048", "volume": "14", "author": "MG Guenther", "year": "2000", "unstructured": "Guenther MG, Lane WS, Fischle W, Verdin E, Lazar MA, Shiekhattar R. A core SMRT corepressor complex containing HDAC3 and TBL1, a WD40-repeat protein linked to deafness. Genes Dev 2000; 14(9):1048\u20131057.", "journal-title": "Genes Dev"}, {"issue": "1", "key": "6_CR89_6", "doi-asserted-by": "publisher", "first-page": "55", "DOI": "10.1016/S0092-8674(02)00809-7", "volume": "110", "author": "SH Baek", "year": "2002", "unstructured": "Baek SH, Ohgi KA, Rose DW, Koo EH, Glass CK, Rosenfeld MG. Exchange of N-CoR corepressor and Tip60 coactivator complexes links gene expression by NF-kappaB and beta-amyloid precursor protein. Cell 2002; 110(1):55\u201367.", "journal-title": "Cell"}, {"issue": "4", "key": "6_CR90_6", "doi-asserted-by": "publisher", "first-page": "511", "DOI": "10.1016/S0092-8674(04)00133-3", "volume": "116", "author": "V Perissi", "year": "2004", "unstructured": "Perissi V, Aggarwal A, Glass CK, Rose DW, Rosenfeld MG. A corepressor/coactivator exchange complex required for transcriptional activation by nuclear receptors and other regulated transcription factors. Cell 2004; 116(4):511\u2013526.", "journal-title": "Cell"}, {"issue": "9", "key": "6_CR91_6", "doi-asserted-by": "publisher", "first-page": "3100", "DOI": "10.1073/pnas.0510842103", "volume": "103", "author": "SH Baek", "year": "2006", "unstructured": "Baek SH, Ohgi KA, Nelson CA, Welsbie D, Chen C, Sawyers CL et al. Ligand-specific allosteric regulation of coactivator functions of androgen receptor in prostate cancer cells. Proc Natl Acad Sci U S A 2006; 103(9):3100\u20133105.", "journal-title": "Proc Natl Acad Sci U S A"}, {"issue": "2", "key": "6_CR92_6", "doi-asserted-by": "publisher", "first-page": "389", "DOI": "10.1016/j.bmcl.2004.10.051", "volume": "15", "author": "ME Salvati", "year": "2005", "unstructured": "Salvati ME, Balog A, Wei DD, Pickering D, Attar RM, Geng J et al. Identification of a novel class of androgen receptor antagonists based on the bicyclic-1H-isoindole-1,3(2H)-dione nucleus. Bioorg Med Chem Lett 2005; 15(2):389\u2013393.", "journal-title": "Bioorg Med Chem Lett"}, {"issue": "1", "key": "6_CR93_6", "doi-asserted-by": "publisher", "first-page": "121", "DOI": "10.1158/1535-7163.MCT-07-0581", "volume": "7", "author": "A Schayowitz", "year": "2008", "unstructured": "Schayowitz A, Sabnis G, Njar VC, Brodie AM. Synergistic effect of a novel antiandrogen, VN/124-1, and signal transduction inhibitors in prostate cancer progression to hormone independence in vitro. Mol Cancer Ther 2008; 7(1):121\u2013132.", "journal-title": "Mol Cancer Ther"}, {"issue": "9", "key": "6_CR94_6", "doi-asserted-by": "publisher", "first-page": "1084", "DOI": "10.1111/j.1464-410X.2008.07509.x", "volume": "101", "author": "ME Taplin", "year": "2008", "unstructured": "Taplin ME, Manola J, Oh WK, Kantoff PW, Bubley GJ, Smith M et al. A phase II study of mifepristone (RU-486) in castration-resistant prostate cancer, with a correlative assessment of androgen-related hormones. BJU Int 2008; 101(9):1084\u20131089.", "journal-title": "BJU Int"}], "container-title": ["Drug Management of Prostate Cancer"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-1-60327-829-4_6", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 13]], "date-time": "2019-05-13T20:01:06Z", "timestamp": 1557777666000}, "score": 43.30252, "issued": {"date-parts": [[2010]]}, "ISBN": ["9781603278317", "9781603278294"], "references-count": 94, "URL": "http://dx.doi.org/10.1007/978-1-60327-829-4_6", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T02:46:20Z", "timestamp": 1574304380950}, "reference-count": 10, "publisher": "Elsevier BV", "issue": "6", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2009, 6, 1]], "date-time": "2009-06-01T00:00:00Z", "timestamp": 1243814400000}, "delay-in-days": 0, "content-version": "tdm"}, {"URL": "https://www.elsevier.com/open-access/userlicense/1.0/", "start": {"date-parts": [[2013, 7, 17]], "date-time": "2013-07-17T00:00:00Z", "timestamp": 1374019200000}, "delay-in-days": 1507, "content-version": "vor"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cancer Cell"], "published-print": {"date-parts": [[2009, 6]]}, "DOI": "10.1016/j.ccr.2009.05.005", "type": "journal-article", "created": {"date-parts": [[2009, 6, 2]], "date-time": "2009-06-02T08:13:05Z", "timestamp": 1243930385000}, "page": "461-463", "source": "Crossref", "is-referenced-by-count": 32, "title": ["Development of Androgen Receptor Antagonists with Promising Activity in Castration-Resistant Prostate Cancer"], "prefix": "10.1016", "volume": "15", "author": [{"given": "Howard C.", "family": "Shen", "sequence": "first", "affiliation": []}, {"given": "Steven P.", "family": "Balk", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Cancer Cell"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1535610809001482?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1535610809001482?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 5, 20]], "date-time": "2019-05-20T14:52:41Z", "timestamp": 1558363961000}, "score": 42.388844, "issued": {"date-parts": [[2009, 6]]}, "references-count": 10, "journal-issue": {"published-print": {"date-parts": [[2009, 6]]}, "issue": "6"}, "alternative-id": ["S1535610809001482"], "URL": "http://dx.doi.org/10.1016/j.ccr.2009.05.005", "ISSN": ["1535-6108"], "issn-type": [{"value": "1535-6108", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T21:22:17Z", "timestamp": 1574716937864}, "reference-count": 0, "publisher": "American Association for Cancer Research", "content-domain": {"domain": ["aacrjournals.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2015, 8, 1]]}, "DOI": "10.1158/1538-7445.am2015-966", "type": "proceedings-article", "created": {"date-parts": [[2015, 8, 5]], "date-time": "2015-08-05T01:35:44Z", "timestamp": 1438738544000}, "update-policy": "http://dx.doi.org/10.1158/aacr-crossmark-policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Abstract 966: LSD1 functions as a global androgen receptor coactivator and is a therapeutic target in prostate cancer"], "prefix": "10.1158", "author": [{"given": "Shuai", "family": "Gao", "sequence": "first", "affiliation": []}, {"given": "Yanfei", "family": "Gao", "sequence": "additional", "affiliation": []}, {"given": "Hansen", "family": "He", "sequence": "additional", "affiliation": []}, {"given": "Myles", "family": "Brown", "sequence": "additional", "affiliation": []}, {"given": "Steve", "family": "Balk", "sequence": "additional", "affiliation": []}, {"given": "Changmeng", "family": "Cai", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2015, 8, 2]]}, "event": {"name": "Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA"}, "container-title": ["Molecular and Cellular Biology"], "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1538-7445.AM2015-966", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 18]], "date-time": "2019-05-18T21:18:19Z", "timestamp": 1558214299000}, "score": 42.258762, "issued": {"date-parts": [[2015, 8, 1]]}, "references-count": 0, "alternative-id": ["10.1158/1538-7445.AM2015-966"], "URL": "http://dx.doi.org/10.1158/1538-7445.am2015-966"}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T15:10:10Z", "timestamp": 1574521810663}, "reference-count": 50, "publisher": "Bioscientifica", "issue": "5", "content-domain": {"domain": ["erc.bioscientifica.com"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2011, 10]]}, "abstract": "<jats:p>The majority of prostate cancers (PCa) express high levels of androgen receptor (AR) and are dependent for their growth on testosterone produced by the testes, which is reduced in the prostate to the higher affinity ligand 5\u03b1-dihydrotestosterone (DHT). PCa growth can be suppressed by androgen deprivation therapy, which involves removal of testicular androgens (surgical or medical castration) or treatment with an AR antagonist (or a combination of both), but patients invariably relapse with tumors that have been termed castration recurrent/resistant PCa (CRPC). Importantly, AR transcriptional activity becomes reactivated at this CRPC stage of the disease and remains essential for tumor growth. The objective of this review is to outline one clinically important mechanism contributing to this AR reactivation, which is increased intratumoral synthesis of testosterone and DHT from weak androgens produced by the adrenal glands and possibly<jats:italic>de novo</jats:italic>from cholesterol. Early studies showed that a substantial fraction of CRPC patients responded to adrenalectomy or medical suppression of adrenal androgen synthesis using agents such as ketoconazole (CYP17A1 inhibitor), and a recent phase III study of a more potent and selective CYP17A1 inhibitor (abiraterone) has demonstrated an improvement in survival. With the pending FDA approval of abiraterone for CRPC, defining the molecular mechanisms contributing to CYP17A1 inhibitor resistance/relapse and AR reactivation is now critical to build on these advances.</jats:p>", "DOI": "10.1530/erc-10-0339", "type": "journal-article", "created": {"date-parts": [[2011, 6, 29]], "date-time": "2011-06-29T00:55:33Z", "timestamp": 1309308933000}, "page": "R175-R182", "update-policy": "http://dx.doi.org/10.1530/crossmarkpolicy-1", "source": "Crossref", "is-referenced-by-count": 66, "title": ["Intratumoral androgen biosynthesis in prostate cancer pathogenesis and response to therapy"], "prefix": "10.1530", "volume": "18", "author": [{"given": "Changmeng", "family": "Cai", "sequence": "first", "affiliation": []}, {"given": "Steven P", "family": "Balk", "sequence": "additional", "affiliation": []}], "member": "416", "reference": [{"issue": "13", "key": "1_36929235", "doi-asserted-by": "publisher", "first-page": "1192", "DOI": "10.1056/NEJMoa0908127", "volume": "362", "author": "Andriole", "year": "2010", "journal-title": "New England Journal of Medicine", "ISSN": "http://id.crossref.org/issn/0028-4793", "issn-type": "print"}, {"issue": "12", "key": "2_35025842", "doi-asserted-by": "publisher", "first-page": "4937", "DOI": "10.1158/0008-5472.CAN-08-4531", "volume": "69", "year": "2009", "journal-title": "Cancer Research", "ISSN": "http://id.crossref.org/issn/0008-5472", "issn-type": "print"}, {"issue": "9", "key": "3_18502279", "doi-asserted-by": "publisher", "first-page": "432", "DOI": "10.1016/j.tem.2004.09.004", "volume": "15", "author": "Auchus", "year": "2004", "journal-title": "Trends in endocrinology and metabolism: TEM", "ISSN": "http://id.crossref.org/issn/1043-2760", "issn-type": "print"}, {"issue": "12", "key": "4_22572120", "doi-asserted-by": "publisher", "first-page": "5806", "DOI": "10.1210/en.2006-0627", "volume": "147", "year": "2006", "journal-title": "Endocrinology", "ISSN": "http://id.crossref.org/issn/0013-7227", "issn-type": "print"}, {"issue": "2", "key": "5_21048145", "doi-asserted-by": "publisher", "first-page": "444", "DOI": "10.1210/me.2005-0287", "volume": "20", "year": "2006", "journal-title": "Molecular Endocrinology", "ISSN": "http://id.crossref.org/issn/0888-8809", "issn-type": "print"}, {"issue": "5", "key": "6_5298435", "doi-asserted-by": "publisher", "first-page": "695", "DOI": "10.1016/0022-4731(89)90514-1", "volume": "32", "author": "B\u00a0\u00a0langer", "year": "1989", "journal-title": "Journal of steroid biochemistry", "ISSN": "http://id.crossref.org/issn/0022-4731", "issn-type": "print"}, {"issue": "10", "key": "7_17936161", "doi-asserted-by": "publisher", "first-page": "473", "DOI": "10.1016/j.tem.2003.10.005", "volume": "14", "author": "B\u00a0\u00a0langer", "year": "2003", "journal-title": "Trends in endocrinology and metabolism: TEM", "ISSN": "http://id.crossref.org/issn/1043-2760", "issn-type": "print"}, {"issue": "9", "key": "8_36630646", "doi-asserted-by": "publisher", "first-page": "1496", "DOI": "10.1200/JCO.2009.25.9259", "volume": "28", "year": "2010", "journal-title": "Journal of Clinical Oncology", "ISSN": "http://id.crossref.org/issn/0732-183X", "issn-type": "print"}, {"issue": "2", "key": "9_17477450", "first-page": "505", "volume": "63", "author": "Desmond", "year": "2003", "journal-title": "Cancer Research", "ISSN": "http://id.crossref.org/issn/0008-5472", "issn-type": "print"}, {"issue": "1-2", "key": "10_31900947", "doi-asserted-by": "publisher", "first-page": "115", "DOI": "10.1016/j.mce.2008.08.013", "volume": "295", "author": "Dillard", "year": "2008", "journal-title": "Molecular and cellular endocrinology", "ISSN": "http://id.crossref.org/issn/0303-7207", "issn-type": "print"}, {"issue": "3", "key": "11_10741845", "doi-asserted-by": "publisher", "first-page": "1481", "DOI": "10.1210/en.140.3.1481", "volume": "140", "author": "El-Alfy", "year": "1999", "journal-title": "Endocrinology", "ISSN": "http://id.crossref.org/issn/0013-7227", "issn-type": "print"}, {"issue": "6", "key": "12_18091480", "doi-asserted-by": "publisher", "first-page": "2212", "DOI": "10.1158/0008-5472.CAN-2148-2", "volume": "64", "author": "Ettinger", "year": "2004", "journal-title": "Cancer Research", "ISSN": "http://id.crossref.org/issn/0008-5472", "issn-type": "print"}, {"key": "13_40654722", "volume": "28", "first-page": "763", "year": "2007", "journal-title": "CONTEMPORARY CLINICAL TRIALS", "DOI": "10.1016/j.cct.2007.05.006", "doi-asserted-by": "crossref"}, {"issue": "2", "key": "14_18640767", "doi-asserted-by": "publisher", "first-page": "174", "DOI": "10.1002/ijc.20704", "volume": "114", "author": "Fromont", "year": "2005", "journal-title": "International journal of cancer. Journal international du cancer", "ISSN": "http://id.crossref.org/issn/0020-7136", "issn-type": "print"}, {"issue": "1 Suppl 1", "key": "15_13449071", "first-page": "28", "volume": "12", "author": "Geller", "year": "1985", "journal-title": "Seminars in oncology", "ISSN": "http://id.crossref.org/issn/0093-7754", "issn-type": "print"}, {"issue": "3", "key": "16_14248899", "doi-asserted-by": "crossref", "first-page": "151", "DOI": "10.1007/BF00254427", "volume": "15", "author": "Geller", "year": "1987", "journal-title": "Urological research", "ISSN": "http://id.crossref.org/issn/0300-5623", "issn-type": "print"}, {"issue": "4", "key": "17_13296949", "doi-asserted-by": "crossref", "first-page": "693", "DOI": "10.1016/S0022-5347(17)49829-6", "volume": "132", "author": "Geller", "year": "1984", "journal-title": "The Journal of urology", "ISSN": "http://id.crossref.org/issn/0022-5347", "issn-type": "print"}, {"issue": "11", "key": "18_31127400", "doi-asserted-by": "publisher", "first-page": "3312", "DOI": "10.1158/1078-0432.CCR-07-4118", "volume": "14", "author": "Hamada", "year": "2008", "journal-title": "Clinical Cancer Research", "ISSN": "http://id.crossref.org/issn/1078-0432", "issn-type": "print"}, {"issue": "3", "key": "19_36399570", "doi-asserted-by": "publisher", "first-page": "1256", "DOI": "10.1158/0008-5472.CAN-09-2092", "volume": "70", "year": "2010", "journal-title": "Cancer Research", "ISSN": "http://id.crossref.org/issn/0008-5472", "issn-type": "print"}, {"issue": "1", "key": "20_17972552", "doi-asserted-by": "crossref", "first-page": "217", "DOI": "10.1016/S0002-9440(10)63112-4", "volume": "164", "author": "Holzbeierlein", "year": "2004", "journal-title": "American Journal Of Pathology", "ISSN": "http://id.crossref.org/issn/0002-9440", "issn-type": "print"}, {"issue": "4", "key": "21_17475822", "doi-asserted-by": "publisher", "first-page": "275", "DOI": "10.1002/pros.10192", "volume": "54", "author": "Ji", "year": "2003", "journal-title": "The Prostate", "ISSN": "http://id.crossref.org/issn/0270-4137", "issn-type": "print"}, {"issue": "3", "key": "22_23605800", "doi-asserted-by": "publisher", "first-page": "1361", "DOI": "10.1158/0008-5472.CAN-06-1593", "volume": "67", "author": "Ji", "year": "2007", "journal-title": "Cancer Research", "ISSN": "http://id.crossref.org/issn/0008-5472", "issn-type": "print"}, {"issue": "10", "key": "23_10642687", "doi-asserted-by": "publisher", "first-page": "421", "DOI": "10.1016/S1043-2760(00)00342-8", "volume": "11", "author": "Labrie", "year": "2000", "journal-title": "Trends in endocrinology and metabolism: TEM", "ISSN": "http://id.crossref.org/issn/1043-2760", "issn-type": "print"}, {"issue": "13", "key": "24_5839462", "doi-asserted-by": "publisher", "first-page": "1971", "DOI": "10.1210/me.11.13.1971", "volume": "11", "author": "Lin", "year": "1997", "journal-title": "Molecular Endocrinology", "ISSN": "http://id.crossref.org/issn/0888-8809", "issn-type": "print"}, {"key": "25_35502487", "ISSN": "http://id.crossref.org/issn/1878-5867", "issn-type": "print", "volume": "69", "first-page": "795", "year": "2004"}, {"issue": "17", "key": "26_29309078", "doi-asserted-by": "publisher", "first-page": "5156", "DOI": "10.1158/1078-0432.CCR-07-0669", "volume": "13", "author": "Lindstrom", "year": "2007", "journal-title": "Clinical Cancer Research", "ISSN": "http://id.crossref.org/issn/1078-0432", "issn-type": "print"}, {"issue": "15", "key": "27_31593603", "doi-asserted-by": "publisher", "first-page": "6407", "DOI": "10.1158/0008-5472.CAN-07-5997", "volume": "68", "author": "Locke", "year": "2008", "journal-title": "Cancer Research", "ISSN": "http://id.crossref.org/issn/0008-5472", "issn-type": "print"}, {"issue": "3-5", "key": "28_34869759", "doi-asserted-by": "publisher", "first-page": "126", "DOI": "10.1016/j.jsbmb.2009.03.011", "volume": "115", "author": "Locke", "year": "2009", "journal-title": "The Journal of steroid biochemistry and molecular biology", "ISSN": "http://id.crossref.org/issn/0960-0760", "issn-type": "print"}, {"issue": "5", "key": "29_6208518", "doi-asserted-by": "crossref", "first-page": "940", "DOI": "10.1093/oxfordjournals.jbchem.a022211", "volume": "124", "author": "Matsuura", "year": "1998", "journal-title": "Journal of Biochemistry", "ISSN": "http://id.crossref.org/issn/0021-924X", "issn-type": "print"}, {"issue": "2", "key": "30_18012856", "doi-asserted-by": "publisher", "first-page": "765", "DOI": "10.1158/0008-5472.CAN-03-0130", "volume": "64", "author": "Mizokami", "year": "2004", "journal-title": "Cancer Research", "ISSN": "http://id.crossref.org/issn/0008-5472", "issn-type": "print"}, {"issue": "2", "key": "31_18026647", "doi-asserted-by": "publisher", "first-page": "440", "DOI": "10.1158/1078-0432.CCR-1146-03", "volume": "10", "author": "Mohler", "year": "2004", "journal-title": "Clinical Cancer Research", "ISSN": "http://id.crossref.org/issn/1078-0432", "issn-type": "print"}, {"issue": "11", "key": "32_31192189", "doi-asserted-by": "publisher", "first-page": "4447", "DOI": "10.1158/0008-5472.CAN-08-0249", "volume": "68", "author": "Montgomery", "year": "2008", "journal-title": "Cancer Research", "ISSN": "http://id.crossref.org/issn/0008-5472", "issn-type": "print"}, {"issue": "10", "key": "33_28687635", "doi-asserted-by": "publisher", "first-page": "5033", "DOI": "10.1158/0008-5472.CAN-06-3332", "volume": "67", "author": "Mostaghel", "year": "2007", "journal-title": "Cancer Research", "ISSN": "http://id.crossref.org/issn/0008-5472", "issn-type": "print"}, {"issue": "4", "key": "34_36522746", "doi-asserted-by": "publisher", "first-page": "1286", "DOI": "10.1158/0008-5472.CAN-09-2509", "volume": "70", "year": "2010", "journal-title": "Cancer Research", "ISSN": "http://id.crossref.org/issn/0008-5472", "issn-type": "print"}, {"issue": "21", "key": "35_18513340", "doi-asserted-by": "publisher", "first-page": "7121", "DOI": "10.1158/1078-0432.CCR-04-0913", "volume": "10", "author": "Nishiyama", "year": "2004", "journal-title": "Clinical Cancer Research", "ISSN": "http://id.crossref.org/issn/1078-0432", "issn-type": "print"}, {"issue": "10", "key": "36_22439465", "doi-asserted-by": "publisher", "first-page": "3850", "DOI": "10.1210/jc.2006-0968", "volume": "91", "year": "2006", "journal-title": "Journal of Clinical Endocrinology &amp; Metabolism", "ISSN": "http://id.crossref.org/issn/0021-972X", "issn-type": "print"}, {"issue": "9", "key": "37_36630628", "doi-asserted-by": "publisher", "first-page": "1489", "DOI": "10.1200/JCO.2009.24.6819", "volume": "28", "year": "2010", "journal-title": "Journal of Clinical Oncology", "ISSN": "http://id.crossref.org/issn/0732-183X", "issn-type": "print"}, {"issue": "7", "key": "38_17678507", "doi-asserted-by": "publisher", "first-page": "2922", "DOI": "10.1210/en.2002-0032", "volume": "144", "year": "2003", "journal-title": "Endocrinology", "ISSN": "http://id.crossref.org/issn/0013-7227", "issn-type": "print"}, {"key": "39_40654723", "volume": "7", "first-page": "90E", "year": "2009", "journal-title": "CLINICAL GENITOURINARY CANCER", "DOI": "10.3816/CGC.2009.n.030", "doi-asserted-by": "crossref"}, {"issue": "5", "key": "40_21655408", "doi-asserted-by": "publisher", "first-page": "2815", "DOI": "10.1158/0008-5472.CAN-05-4000", "volume": "66", "author": "Stanbrough", "year": "2006", "journal-title": "Cancer Research", "ISSN": "http://id.crossref.org/issn/0008-5472", "issn-type": "print"}, {"issue": "11", "key": "41_19566616", "doi-asserted-by": "publisher", "first-page": "10784", "DOI": "10.1074/jbc.M313308200", "volume": "279", "year": "2004", "journal-title": "Journal of Biological Chemistry", "ISSN": "http://id.crossref.org/issn/0021-9258", "issn-type": "print"}, {"issue": "22", "key": "42_35898847", "doi-asserted-by": "publisher", "first-page": "7099", "DOI": "10.1158/1078-0432.CCR-09-1722", "volume": "15", "year": "2009", "journal-title": "Clinical Cancer Research", "ISSN": "http://id.crossref.org/issn/1078-0432", "issn-type": "print"}, {"issue": "3", "key": "43_19229212", "doi-asserted-by": "publisher", "first-page": "215", "DOI": "10.1056/NEJMoa030660", "volume": "349", "year": "2003", "journal-title": "New England Journal of Medicine", "ISSN": "http://id.crossref.org/issn/0028-4793", "issn-type": "print"}, {"issue": "12", "key": "44_18928316", "doi-asserted-by": "publisher", "first-page": "4365", "DOI": "10.1158/1078-0432.CCR-04-0738", "volume": "11", "author": "Titus", "year": "2005", "journal-title": "Clinical Cancer Research", "ISSN": "http://id.crossref.org/issn/1078-0432", "issn-type": "print"}, {"issue": "13", "key": "45_19251842", "doi-asserted-by": "publisher", "first-page": "4653", "DOI": "10.1158/1078-0432.CCR-05-0525", "volume": "11", "author": "Titus", "year": "2005", "journal-title": "Clinical Cancer Research", "ISSN": "http://id.crossref.org/issn/1078-0432", "issn-type": "print"}, {"issue": "1", "key": "46_30106215", "first-page": "81", "volume": "99", "author": "Uemura", "year": "2008", "journal-title": "Cancer Science", "ISSN": "http://id.crossref.org/issn/0910-5050", "issn-type": "print"}, {"issue": "2", "key": "47_9256866", "doi-asserted-by": "publisher", "first-page": "534", "DOI": "10.1016/S0006-291X(05)80067-1", "volume": "173", "author": "Veldscholte", "year": "1990", "journal-title": "Biochemical and biophysical research communications", "ISSN": "http://id.crossref.org/issn/0006-291X", "issn-type": "print"}, {"issue": "12", "key": "48_9759452", "doi-asserted-by": "publisher", "first-page": "857", "DOI": "10.1016/0024-3205(92)90204-3", "volume": "50", "author": "van Weerden", "year": "1992", "journal-title": "Life sciences", "ISSN": "http://id.crossref.org/issn/0024-3205", "issn-type": "print"}, {"issue": "21", "key": "49_19674035", "doi-asserted-by": "publisher", "first-page": "13589", "DOI": "10.1073/pnas.162477299", "volume": "99", "year": "2002", "journal-title": "PNAS", "ISSN": "http://id.crossref.org/issn/0027-8424", "issn-type": "print"}, {"issue": "1", "key": "50_33403569", "doi-asserted-by": "crossref", "first-page": "36", "DOI": "10.1016/j.urolonc.2008.03.021", "volume": "27", "author": "Yuan", "year": "2009", "journal-title": "Urologic oncology", "ISSN": "http://id.crossref.org/issn/1078-1439", "issn-type": "print"}], "container-title": ["Endocrine-Related Cancer"], "link": [{"URL": "https://erc.bioscientifica.com/view/journals/erc/18/5/R175.xml", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 6, 12]], "date-time": "2019-06-12T13:45:21Z", "timestamp": 1560347121000}, "score": 41.850784, "issued": {"date-parts": [[2011, 6, 28]]}, "references-count": 50, "journal-issue": {"issue": "5"}, "URL": "http://dx.doi.org/10.1530/erc-10-0339", "relation": {"cites": []}, "ISSN": ["1351-0088", "1479-6821"], "issn-type": [{"value": "1351-0088", "type": "print"}, {"value": "1479-6821", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 5]], "date-time": "2019-12-05T10:22:13Z", "timestamp": 1575541333907}, "reference-count": 0, "publisher": "American Association for Cancer Research (AACR)", "issue": "11", "funder": [{"DOI": "10.13039/100000002", "name": "National Institutes of Health", "doi-asserted-by": "publisher", "award": ["P50 CA090381", "P01 CA163227"]}, {"DOI": "10.13039/100000005", "name": "U.S. Department of Defense", "doi-asserted-by": "publisher", "award": ["W81XWH-16-1-0431"]}, {"name": "Early Investigator Research", "award": ["PC170570"]}], "content-domain": {"domain": ["aacrjournals.org"], "crossmark-restriction": true}, "short-container-title": ["Cancer Discov"], "published-print": {"date-parts": [[2019, 11]]}, "DOI": "10.1158/2159-8290.cd-19-1028", "type": "journal-article", "created": {"date-parts": [[2019, 11, 1]], "date-time": "2019-11-01T12:44:19Z", "timestamp": 1572612259000}, "page": "1490-1492", "update-policy": "http://dx.doi.org/10.1158/aacr-crossmark-policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Androgen Receptor Interaction with Mediator Complex Is Enhanced in Castration-Resistant Prostate Cancer by CDK7 Phosphorylation of MED1"], "prefix": "10.1158", "volume": "9", "author": [{"given": "Joshua W.", "family": "Russo", "sequence": "first", "affiliation": []}, {"given": "Mannan", "family": "Nouri", "sequence": "additional", "affiliation": []}, {"given": "Steven P.", "family": "Balk", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2019, 11, 1]]}, "container-title": ["Cancer Discovery"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/2159-8290.CD-19-1028", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 1]], "date-time": "2019-11-01T12:44:33Z", "timestamp": 1572612273000}, "score": 40.835884, "issued": {"date-parts": [[2019, 11]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2019, 11, 1]]}, "published-print": {"date-parts": [[2019, 11]]}, "issue": "11"}, "alternative-id": ["10.1158/2159-8290.CD-19-1028"], "URL": "http://dx.doi.org/10.1158/2159-8290.cd-19-1028", "ISSN": ["2159-8274", "2159-8290"], "issn-type": [{"value": "2159-8274", "type": "print"}, {"value": "2159-8290", "type": "electronic"}], "subject": ["Oncology"]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T06:33:05Z", "timestamp": 1574490785530}, "reference-count": 0, "publisher": "American Association for Cancer Research", "content-domain": {"domain": ["aacrjournals.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2011, 4, 15]]}, "DOI": "10.1158/1538-7445.am2011-lb-420", "type": "proceedings-article", "created": {"date-parts": [[2012, 7, 21]], "date-time": "2012-07-21T08:15:47Z", "timestamp": 1342858547000}, "update-policy": "http://dx.doi.org/10.1158/aacr-crossmark-policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Abstract LB-420: Intratumoral de novo steroid synthesis mediates prostate cancer resistance to androgen deprivation and CYP17a1 inhibition"], "prefix": "10.1158", "author": [{"given": "Changmeng", "family": "Cai", "sequence": "first", "affiliation": []}, {"given": "Steven P.", "family": "Balk", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2014, 11, 13]]}, "event": {"name": "Proceedings: AACR 102nd Annual Meeting 2011\u2010\u2010 Apr 2\u20106, 2011; Orlando, FL"}, "container-title": ["Endocrinology"], "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1538-7445.AM2011-LB-420", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 18]], "date-time": "2019-05-18T22:08:09Z", "timestamp": 1558217289000}, "score": 40.307266, "issued": {"date-parts": [[2011, 4, 15]]}, "references-count": 0, "alternative-id": ["10.1158/1538-7445.AM2011-LB-420"], "URL": "http://dx.doi.org/10.1158/1538-7445.am2011-lb-420"}, {"indexed": {"date-parts": [[2019, 12, 21]], "date-time": "2019-12-21T02:23:13Z", "timestamp": 1576894993722}, "reference-count": 57, "publisher": "Wiley", "issue": "3", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 4261, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["J. Cell. Biochem."], "published-print": {"date-parts": [[2004, 2, 15]]}, "DOI": "10.1002/jcb.10653", "type": "journal-article", "created": {"date-parts": [[2004, 1, 27]], "date-time": "2004-01-27T11:30:47Z", "timestamp": 1075203047000}, "page": "483-190", "source": "Crossref", "is-referenced-by-count": 226, "title": ["Androgen receptor: A key molecule in the progression of prostate cancer to hormone independence"], "prefix": "10.1002", "volume": "91", "author": [{"given": "Mary-Ellen", "family": "Taplin", "sequence": "first", "affiliation": []}, {"given": "Steven P.", "family": "Balk", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2004]]}, "reference": [{"key": "10.1002/jcb.10653-BIB1", "author": "Bola", "volume": "337", "first-page": "295", "year": "1997", "journal-title": "N Engl J Med", "DOI": "10.1056/NEJM199707313370502", "doi-asserted-by": "crossref"}, {"key": "10.1002/jcb.10653-BIB2", "author": "Brinkmann", "volume": "34", "first-page": "307", "year": "1989", "journal-title": "J Steroid Biochem", "DOI": "10.1016/0022-4731(89)90098-8", "doi-asserted-by": "crossref"}, {"key": "10.1002/jcb.10653-BIB3", "author": "Buchanan", "volume": "7", "first-page": "1273", "year": "2001", "journal-title": "Clin Cancer Res"}, {"key": "10.1002/jcb.10653-BIB4", "author": "Caskey", "volume": "256", "first-page": "784", "year": "1992", "journal-title": "Science", "DOI": "10.1126/science.1589758", "doi-asserted-by": "crossref"}, {"key": "10.1002/jcb.10653-BIB5", "author": "Chamberlain", "volume": "22", "first-page": "3181", "year": "1994", "journal-title": "Nucleic Acids Res", "DOI": "10.1093/nar/22.15.3181", "doi-asserted-by": "crossref"}, {"key": "10.1002/jcb.10653-BIB6", "author": "Choong", "volume": "10", "first-page": "1527", "year": "1996", "journal-title": "Mol Endocrinol"}, {"key": "10.1002/jcb.10653-BIB7", "author": "Culig", "volume": "54", "first-page": "5474", "year": "1994", "journal-title": "Cancer Res"}, {"key": "10.1002/jcb.10653-BIB8", "author": "de Vere White", "volume": "31", "first-page": "1", "year": "1997", "journal-title": "Eur Urol", "DOI": "10.1159/000474409", "doi-asserted-by": "crossref"}, {"key": "10.1002/jcb.10653-BIB9", "author": "Debes", "volume": "15", "first-page": "5632", "year": "2002", "journal-title": "Cancer Res"}, {"key": "10.1002/jcb.10653-BIB10", "author": "Evans", "volume": "240", "first-page": "889", "year": "1988", "journal-title": "Science", "DOI": "10.1126/science.3283939", "doi-asserted-by": "crossref"}, {"key": "10.1002/jcb.10653-BIB11", "author": "Faber", "volume": "61", "first-page": "257", "year": "1989", "journal-title": "Mol Cell Endocrinol", "DOI": "10.1016/0303-7207(89)90137-8", "doi-asserted-by": "crossref"}, {"key": "10.1002/jcb.10653-BIB12", "author": "Gelmann", "volume": "20", "first-page": "3001", "year": "2002", "journal-title": "J Clin Oncol", "DOI": "10.1200/JCO.2002.10.018", "doi-asserted-by": "crossref"}, {"key": "10.1002/jcb.10653-BIB13", "author": "Giovannucci", "volume": "94", "first-page": "3320", "year": "1997", "journal-title": "Proc Natl Acad Sci", "DOI": "10.1073/pnas.94.7.3320", "doi-asserted-by": "crossref"}, {"key": "10.1002/jcb.10653-BIB14", "author": "Gottlieb", "volume": "26", "first-page": "234", "year": "1998", "journal-title": "Nucleic Acids Res", "DOI": "10.1093/nar/26.1.234", "doi-asserted-by": "crossref"}, {"key": "10.1002/jcb.10653-BIB15", "author": "Gregory", "volume": "61", "first-page": "4315", "year": "2001", "journal-title": "Cancer Res"}, {"key": "10.1002/jcb.10653-BIB16", "author": "Griffin", "volume": "326", "first-page": "611", "year": "1992", "journal-title": "N Engl J Med", "DOI": "10.1056/NEJM199202273260906", "doi-asserted-by": "crossref"}, {"key": "10.1002/jcb.10653-BIB17", "author": "Grossmann", "volume": "93", "first-page": "1687", "year": "2001", "journal-title": "J Natl Cancer Inst", "DOI": "10.1093/jnci/93.22.1687", "doi-asserted-by": "crossref"}, {"key": "10.1002/jcb.10653-BIB18", "author": "Halkidou", "volume": "22", "first-page": "2466", "year": "2003", "journal-title": "Oncogene", "DOI": "10.1038/sj.onc.1206342", "doi-asserted-by": "crossref"}, {"key": "10.1002/jcb.10653-BIB19", "author": "Hara", "volume": "63", "first-page": "149", "year": "2003", "journal-title": "Cancer Res"}, {"key": "10.1002/jcb.10653-BIB20", "author": "Heinlein", "volume": "23", "first-page": "175", "year": "2002", "journal-title": "Endocr Rev", "DOI": "10.1210/edrv.23.2.0460", "doi-asserted-by": "crossref"}, {"key": "10.1002/jcb.10653-BIB21", "author": "Henshall", "volume": "61", "first-page": "423", "year": "2001", "journal-title": "Cancer Res"}, {"key": "10.1002/jcb.10653-BIB22", "author": "Horoszewicz", "volume": "43", "first-page": "1809", "year": "1983", "journal-title": "Cancer Res"}, {"key": "10.1002/jcb.10653-BIB23", "author": "Irvine", "volume": "55", "first-page": "1937", "year": "1995", "journal-title": "Cancer Res"}, {"key": "10.1002/jcb.10653-BIB24", "author": "Jemal", "volume": "52", "first-page": "23", "year": "2002", "journal-title": "CA Cancer J Clin", "DOI": "10.3322/canjclin.52.1.23", "doi-asserted-by": "crossref"}, {"key": "10.1002/jcb.10653-BIB25", "author": "Jenster", "volume": "5", "first-page": "1396", "year": "1991", "journal-title": "Mol Endocrinol", "DOI": "10.1210/mend-5-10-1396", "doi-asserted-by": "crossref"}, {"key": "10.1002/jcb.10653-BIB26", "author": "Joyce", "volume": "159", "first-page": "149", "year": "1998", "journal-title": "J Urol", "DOI": "10.1016/S0022-5347(01)64039-4", "doi-asserted-by": "crossref"}, {"key": "10.1002/jcb.10653-BIB27", "author": "Koivisto", "volume": "57", "first-page": "314", "year": "1997", "journal-title": "Cancer Res"}, {"key": "10.1002/jcb.10653-BIB28", "author": "Krishnan", "volume": "143", "first-page": "1889", "year": "2002", "journal-title": "Endocrinology", "DOI": "10.1210/endo.143.5.8778", "doi-asserted-by": "crossref"}, {"key": "10.1002/jcb.10653-BIB29", "author": "Linja", "volume": "61", "first-page": "3550", "year": "2001", "journal-title": "Cancer Res"}, {"key": "10.1002/jcb.10653-BIB30", "author": "Marcelli", "volume": "60", "first-page": "944", "year": "2000", "journal-title": "Cancer Res"}, {"key": "10.1002/jcb.10653-BIB31", "author": "Matias", "volume": "275", "first-page": "26164", "year": "2000", "journal-title": "J Biol Chem", "DOI": "10.1074/jbc.M004571200", "doi-asserted-by": "crossref"}, {"key": "10.1002/jcb.10653-BIB32", "author": "Messing", "volume": "341", "first-page": "1781", "year": "1999", "journal-title": "N Engl J Med", "DOI": "10.1056/NEJM199912093412401", "doi-asserted-by": "crossref"}, {"key": "10.1002/jcb.10653-BIB33", "author": "Miyoshi", "volume": "43", "first-page": "225", "year": "2000", "journal-title": "Prostate", "DOI": "10.1002/(SICI)1097-0045(20000515)43:3<225::AID-PROS9>3.0.CO;2-7", "doi-asserted-by": "crossref"}, {"key": "10.1002/jcb.10653-BIB34", "author": "Morris", "volume": "15", "first-page": "980", "year": "2002", "journal-title": "Cancer", "DOI": "10.1002/cncr.10339", "doi-asserted-by": "crossref"}, {"key": "10.1002/jcb.10653-BIB35", "author": "Navarro", "volume": "81", "first-page": "191", "year": "2002", "journal-title": "J Steroid Biochem Mol Biol", "DOI": "10.1016/S0960-0760(02)00064-X", "doi-asserted-by": "crossref"}, {"key": "10.1002/jcb.10653-BIB36", "author": "Palmberg", "volume": "164", "first-page": "1992", "year": "2000", "journal-title": "J Urol", "DOI": "10.1016/S0022-5347(05)66935-2", "doi-asserted-by": "crossref"}, {"key": "10.1002/jcb.10653-BIB37", "author": "Prins", "volume": "75", "first-page": "s32", "year": "2000", "journal-title": "Mayo Clin Proc"}, {"key": "10.1002/jcb.10653-BIB38", "author": "Rahman", "volume": "278", "first-page": "19619", "year": "2003", "journal-title": "J Biol Chem", "DOI": "10.1074/jbc.M210941200", "doi-asserted-by": "crossref"}, {"key": "10.1002/jcb.10653-BIB39", "author": "Ruizeveld de Winter", "volume": "39", "first-page": "927", "year": "1991", "journal-title": "J Histochem Cytochem", "DOI": "10.1177/39.7.1865110", "doi-asserted-by": "crossref"}, {"key": "10.1002/jcb.10653-BIB40", "author": "Sack", "volume": "98", "first-page": "4904", "year": "2001", "journal-title": "PNAS", "DOI": "10.1073/pnas.081565498", "doi-asserted-by": "crossref"}, {"key": "10.1002/jcb.10653-BIB41", "author": "Savarese", "volume": "19", "first-page": "2509", "year": "2001", "journal-title": "J Clin Oncol", "DOI": "10.1200/JCO.2001.19.9.2509", "doi-asserted-by": "crossref"}, {"key": "10.1002/jcb.10653-BIB42", "author": "Scher", "volume": "15", "first-page": "2928", "year": "1997", "journal-title": "J Clin Oncol", "DOI": "10.1200/JCO.1997.15.8.2928", "doi-asserted-by": "crossref"}, {"key": "10.1002/jcb.10653-BIB43", "author": "Schoenberg", "volume": "198", "first-page": "74", "year": "1994", "journal-title": "Biochem Biophys Res Commun", "DOI": "10.1006/bbrc.1994.1011", "doi-asserted-by": "crossref"}, {"key": "10.1002/jcb.10653-BIB44", "author": "Shariat", "volume": "58", "first-page": "1008", "year": "2001", "journal-title": "Urology", "DOI": "10.1016/S0090-4295(01)01405-4", "doi-asserted-by": "crossref"}, {"key": "10.1002/jcb.10653-BIB45", "author": "Small", "volume": "15", "first-page": "382", "year": "1997", "journal-title": "J Clin Oncol", "DOI": "10.1200/JCO.1997.15.1.382", "doi-asserted-by": "crossref"}, {"key": "10.1002/jcb.10653-BIB46", "author": "Small", "volume": "28", "first-page": "71", "year": "2001", "journal-title": "Semin Oncol", "DOI": "10.1016/S0093-7754(01)90159-9", "doi-asserted-by": "crossref"}, {"key": "10.1002/jcb.10653-BIB47", "author": "Suzuki", "volume": "46", "first-page": "759", "year": "1993", "journal-title": "J Steroid Biochem Mol Biol", "DOI": "10.1016/0960-0760(93)90316-O", "doi-asserted-by": "crossref"}, {"key": "10.1002/jcb.10653-BIB48", "author": "Taplin", "volume": "332", "first-page": "1393", "year": "1995", "journal-title": "N Engl J Med", "DOI": "10.1056/NEJM199505253322101", "doi-asserted-by": "crossref"}, {"key": "10.1002/jcb.10653-BIB49", "author": "Taplin", "volume": "59", "first-page": "2511", "year": "1999", "journal-title": "Cancer Res"}, {"key": "10.1002/jcb.10653-BIB50", "author": "Taplin", "volume": "21", "first-page": "2673", "year": "2003", "journal-title": "J Clin Oncol", "DOI": "10.1200/JCO.2003.11.102", "doi-asserted-by": "crossref"}, {"key": "10.1002/jcb.10653-BIB51", "author": "Tilley", "volume": "2", "first-page": "277", "year": "1996", "journal-title": "Clin Cancer Res"}, {"key": "10.1002/jcb.10653-BIB52", "author": "Ueda", "volume": "277", "first-page": "7076", "year": "2002a", "journal-title": "J Biol Chem", "DOI": "10.1074/jbc.M108255200", "doi-asserted-by": "crossref"}, {"key": "10.1002/jcb.10653-BIB53", "author": "Ueda", "volume": "277", "first-page": "38087", "year": "2002b", "journal-title": "J Biol Chem", "DOI": "10.1074/jbc.M203313200", "doi-asserted-by": "crossref"}, {"key": "10.1002/jcb.10653-BIB54", "author": "Veldscholte", "volume": "173", "first-page": "534", "year": "1990", "journal-title": "Biochem Biophys Res Commun", "DOI": "10.1016/S0006-291X(05)80067-1", "doi-asserted-by": "crossref"}, {"key": "10.1002/jcb.10653-BIB55", "author": "Veldscholte", "volume": "31", "first-page": "7422", "year": "1992", "journal-title": "Biochemistry", "DOI": "10.1021/bi00147a029", "doi-asserted-by": "crossref"}, {"key": "10.1002/jcb.10653-BIB56", "author": "Visakorpi", "volume": "9", "first-page": "401", "year": "1995", "journal-title": "Nat Genet", "DOI": "10.1038/ng0495-401", "doi-asserted-by": "crossref"}, {"key": "10.1002/jcb.10653-BIB57", "author": "Wang", "volume": "259", "first-page": "21", "year": "1999", "journal-title": "Biochem Biophys Res Commun", "DOI": "10.1006/bbrc.1999.0655", "doi-asserted-by": "crossref"}], "container-title": ["Journal of Cellular Biochemistry"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fjcb.10653", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/jcb.10653", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 8, 4]], "date-time": "2018-08-04T02:58:45Z", "timestamp": 1533351525000}, "score": 39.958748, "issued": {"date-parts": [[2004]]}, "references-count": 57, "journal-issue": {"published-print": {"date-parts": [[2004, 2, 15]]}, "issue": "3"}, "URL": "http://dx.doi.org/10.1002/jcb.10653", "relation": {"cites": []}, "ISSN": ["0730-2312", "1097-4644"], "issn-type": [{"value": "0730-2312", "type": "print"}, {"value": "1097-4644", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 19]], "date-time": "2019-12-19T23:54:12Z", "timestamp": 1576799652775}, "reference-count": 28, "publisher": "American Society of Clinical Oncology (ASCO)", "issue": "19", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JCO"], "published-print": {"date-parts": [[2017, 7, 1]]}, "DOI": "10.1200/jco.2017.72.8808", "type": "journal-article", "created": {"date-parts": [[2017, 4, 17]], "date-time": "2017-04-17T19:59:18Z", "timestamp": 1492459158000}, "page": "2103-2105", "source": "Crossref", "is-referenced-by-count": 5, "title": ["Association Between Androgen Receptor Splice Variants and Prostate Cancer Resistance to Abiraterone and Enzalutamide"], "prefix": "10.1200", "volume": "35", "author": [{"given": "Glenn J.", "family": "Bubley", "sequence": "first", "affiliation": [{"name": "Glenn J. Bubley and Steven P. Balk, Beth Israel Deaconess Medical Center, Boston, MA"}]}, {"given": "Steven P.", "family": "Balk", "sequence": "additional", "affiliation": [{"name": "Glenn J. Bubley and Steven P. Balk, Beth Israel Deaconess Medical Center, Boston, MA"}]}], "member": "233", "container-title": ["Journal of Clinical Oncology"], "language": "en", "link": [{"URL": "http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2017.72.8808", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T20:33:38Z", "timestamp": 1574886818000}, "score": 39.958748, "issued": {"date-parts": [[2017, 7, 1]]}, "references-count": 28, "journal-issue": {"published-print": {"date-parts": [[2017, 7, 1]]}, "issue": "19"}, "alternative-id": ["10.1200/JCO.2017.72.8808"], "URL": "http://dx.doi.org/10.1200/jco.2017.72.8808", "ISSN": ["0732-183X", "1527-7755"], "issn-type": [{"value": "0732-183X", "type": "print"}, {"value": "1527-7755", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T04:19:41Z", "timestamp": 1574309981541}, "reference-count": 0, "publisher": "American Association for Cancer Research (AACR)", "issue": "15", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cancer Research"], "published-print": {"date-parts": [[2009, 8, 1]]}, "DOI": "10.1158/0008-5472.can-09-0395", "type": "journal-article", "created": {"date-parts": [[2009, 7, 8]], "date-time": "2009-07-08T03:24:27Z", "timestamp": 1247023467000}, "page": "6027-6032", "source": "Crossref", "is-referenced-by-count": 68, "title": ["Reactivation of Androgen Receptor-Regulated TMPRSS2:ERG Gene Expression in Castration-Resistant Prostate Cancer"], "prefix": "10.1158", "volume": "69", "author": [{"given": "C.", "family": "Cai", "sequence": "first", "affiliation": []}, {"given": "H.", "family": "Wang", "sequence": "additional", "affiliation": []}, {"given": "Y.", "family": "Xu", "sequence": "additional", "affiliation": []}, {"given": "S.", "family": "Chen", "sequence": "additional", "affiliation": []}, {"given": "S. P.", "family": "Balk", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2009, 7, 7]]}, "container-title": ["Cancer Research"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/0008-5472.CAN-09-0395", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T08:54:22Z", "timestamp": 1482483262000}, "score": 38.904587, "issued": {"date-parts": [[2009, 7, 7]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2009, 7, 29]]}, "published-print": {"date-parts": [[2009, 8, 1]]}, "issue": "15"}, "URL": "http://dx.doi.org/10.1158/0008-5472.can-09-0395", "ISSN": ["0008-5472", "1538-7445"], "issn-type": [{"value": "0008-5472", "type": "print"}, {"value": "1538-7445", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T02:39:22Z", "timestamp": 1574131162781}, "reference-count": 35, "publisher": "Massachusetts Medical Society", "issue": "21", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["N Engl J Med"], "published-print": {"date-parts": [[1995, 5, 25]]}, "DOI": "10.1056/nejm199505253322101", "type": "journal-article", "created": {"date-parts": [[2002, 7, 27]], "date-time": "2002-07-27T12:50:34Z", "timestamp": 1027774234000}, "page": "1393-1398", "source": "Crossref", "is-referenced-by-count": 737, "title": ["Mutation of the Androgen-Receptor Gene in Metastatic Androgen-Independent Prostate Cancer"], "prefix": "10.1056", "volume": "332", "author": [{"given": "Mary-Ellen", "family": "Taplin", "sequence": "first", "affiliation": []}, {"given": "Glenn J.", "family": "Bubley", "sequence": "additional", "affiliation": []}, {"given": "Todd D.", "family": "Shuster", "sequence": "additional", "affiliation": []}, {"given": "Martha E.", "family": "Frantz", "sequence": "additional", "affiliation": []}, {"given": "Amy E.", "family": "Spooner", "sequence": "additional", "affiliation": []}, {"given": "George K.", "family": "Ogata", "sequence": "additional", "affiliation": []}, {"given": "Harold N.", "family": "Keer", "sequence": "additional", "affiliation": []}, {"given": "Steven P.", "family": "Balk", "sequence": "additional", "affiliation": []}], "member": "150", "container-title": ["New England Journal of Medicine"], "language": "en", "link": [{"URL": "http://www.nejm.org/doi/pdf/10.1056/NEJM199505253322101", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 12, 16]], "date-time": "2017-12-16T21:15:45Z", "timestamp": 1513458945000}, "score": 38.747776, "issued": {"date-parts": [[1995, 5, 25]]}, "references-count": 35, "journal-issue": {"published-print": {"date-parts": [[1995, 5, 25]]}, "issue": "21"}, "alternative-id": ["10.1056/NEJM199505253322101"], "URL": "http://dx.doi.org/10.1056/nejm199505253322101", "ISSN": ["0028-4793", "1533-4406"], "issn-type": [{"value": "0028-4793", "type": "print"}, {"value": "1533-4406", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T05:06:21Z", "timestamp": 1574226381613}, "reference-count": 50, "publisher": "Elsevier BV", "issue": "2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2006, 8, 1]], "date-time": "2006-08-01T00:00:00Z", "timestamp": 1154390400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["The American Journal of Pathology"], "published-print": {"date-parts": [[2006, 8]]}, "DOI": "10.2353/ajpath.2006.051047", "type": "journal-article", "created": {"date-parts": [[2006, 8, 21]], "date-time": "2006-08-21T21:19:07Z", "timestamp": 1156195147000}, "page": "682-696", "source": "Crossref", "is-referenced-by-count": 43, "title": ["Androgen Receptor Remains Critical for Cell-Cycle Progression in Androgen-Independent CWR22 Prostate Cancer Cells"], "prefix": "10.1016", "volume": "169", "author": [{"given": "Xin", "family": "Yuan", "sequence": "first", "affiliation": []}, {"given": "Tong", "family": "Li", "sequence": "additional", "affiliation": []}, {"given": "Hongyun", "family": "Wang", "sequence": "additional", "affiliation": []}, {"given": "Tao", "family": "Zhang", "sequence": "additional", "affiliation": []}, {"given": "Moumita", "family": "Barua", "sequence": "additional", "affiliation": []}, {"given": "Robert A.", "family": "Borgesi", "sequence": "additional", "affiliation": []}, {"given": "Glenn J.", "family": "Bubley", "sequence": "additional", "affiliation": []}, {"given": "Michael L.", "family": "Lu", "sequence": "additional", "affiliation": []}, {"given": "Steven P.", "family": "Balk", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["The American Journal of Pathology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0002944010627472?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0002944010627472?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 1, 14]], "date-time": "2019-01-14T03:59:01Z", "timestamp": 1547438341000}, "score": 38.747776, "issued": {"date-parts": [[2006, 8]]}, "references-count": 50, "journal-issue": {"published-print": {"date-parts": [[2006, 8]]}, "issue": "2"}, "alternative-id": ["S0002944010627472"], "URL": "http://dx.doi.org/10.2353/ajpath.2006.051047", "ISSN": ["0002-9440"], "issn-type": [{"value": "0002-9440", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T08:09:44Z", "timestamp": 1574410184974}, "reference-count": 38, "publisher": "Elsevier BV", "issue": "4", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2011, 10, 1]], "date-time": "2011-10-01T00:00:00Z", "timestamp": 1317427200000}, "delay-in-days": 0, "content-version": "tdm"}, {"URL": "https://www.elsevier.com/open-access/userlicense/1.0/", "start": {"date-parts": [[2013, 8, 22]], "date-time": "2013-08-22T00:00:00Z", "timestamp": 1377129600000}, "delay-in-days": 691, "content-version": "vor"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cancer Cell"], "published-print": {"date-parts": [[2011, 10]]}, "DOI": "10.1016/j.ccr.2011.09.001", "type": "journal-article", "created": {"date-parts": [[2011, 10, 18]], "date-time": "2011-10-18T06:12:44Z", "timestamp": 1318918364000}, "page": "457-471", "source": "Crossref", "is-referenced-by-count": 190, "title": ["Androgen Receptor Gene Expression in Prostate Cancer Is Directly Suppressed by the Androgen Receptor Through Recruitment of Lysine-Specific Demethylase 1"], "prefix": "10.1016", "volume": "20", "author": [{"given": "Changmeng", "family": "Cai", "sequence": "first", "affiliation": []}, {"given": "Housheng\u00a0Hansen", "family": "He", "sequence": "additional", "affiliation": []}, {"given": "Sen", "family": "Chen", "sequence": "additional", "affiliation": []}, {"given": "Ilsa", "family": "Coleman", "sequence": "additional", "affiliation": []}, {"given": "Hongyun", "family": "Wang", "sequence": "additional", "affiliation": []}, {"given": "Zi", "family": "Fang", "sequence": "additional", "affiliation": []}, {"given": "Shaoyong", "family": "Chen", "sequence": "additional", "affiliation": []}, {"given": "Peter\u00a0S.", "family": "Nelson", "sequence": "additional", "affiliation": []}, {"given": "X.\u00a0Shirley", "family": "Liu", "sequence": "additional", "affiliation": []}, {"given": "Myles", "family": "Brown", "sequence": "additional", "affiliation": []}, {"given": "Steven\u00a0P.", "family": "Balk", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Cancer Cell"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1535610811003205?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1535610811003205?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 6, 17]], "date-time": "2019-06-17T21:38:36Z", "timestamp": 1560807516000}, "score": 38.504696, "issued": {"date-parts": [[2011, 10]]}, "references-count": 38, "journal-issue": {"published-print": {"date-parts": [[2011, 10]]}, "issue": "4"}, "alternative-id": ["S1535610811003205"], "URL": "http://dx.doi.org/10.1016/j.ccr.2011.09.001", "ISSN": ["1535-6108"], "issn-type": [{"value": "1535-6108", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T01:25:54Z", "timestamp": 1575422754121}, "reference-count": 88, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Current Opinion in Oncology"], "published-print": {"date-parts": [[2019, 5]]}, "DOI": "10.1097/cco.0000000000000520", "type": "journal-article", "created": {"date-parts": [[2019, 3, 21]], "date-time": "2019-03-21T11:56:30Z", "timestamp": 1553169390000}, "page": "175-182", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Targeting the androgen receptor and overcoming resistance in prostate cancer"], "prefix": "10.1097", "volume": "31", "author": [{"given": "David J.", "family": "Einstein", "sequence": "first", "affiliation": []}, {"given": "Seiji", "family": "Arai", "sequence": "additional", "affiliation": []}, {"given": "Steven P.", "family": "Balk", "sequence": "additional", "affiliation": []}], "member": "276", "container-title": ["Current Opinion in Oncology"], "language": "en", "link": [{"URL": "http://journals.lww.com/co-oncology/Fulltext/10.1097/CCO.0000000000000520", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 20]], "date-time": "2019-05-20T11:49:35Z", "timestamp": 1558352975000}, "score": 38.40579, "subtitle": [""], "issued": {"date-parts": [[2019, 5]]}, "references-count": 88, "journal-issue": {"issue": "3"}, "URL": "http://dx.doi.org/10.1097/cco.0000000000000520", "ISSN": ["1040-8746"], "issn-type": [{"value": "1040-8746", "type": "print"}], "subject": ["Cancer Research", "Oncology"]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}